Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE004260 |
ID: | TCMBANKHE004260 |
植物拉丁名: |
|
功能与主治: | To reinforce the vital energy, to remedy collapse and restore the normal pulse, to benefit the spleen and lung, to promote the production of body fluid, and to calm the nerves./Qi vacuity and verging on desertion, cold limbs and faint pulse, reduced food intake due to spleen vacuity, cough and asthma due to lung vacuity, fluid damage and thirst, diabetes mellitus due to internal heat, enduring illness qi vacuity, fright palpitation and insomnia, impotence, uterus cold, cardiac failure. |
药用植物名: | 人参 |
药用部位: | root |
药味: | Minor Warm; Sweet; Slightly Bitter |
经络: | Lung; Spleen; Heart |
临床特征: | 1. Acting on the central nervous system including excitation and inhibition processes.2. Exerting significant cardiotonic and hypertensive effects on acute circulatory failure cardiotonic and hypertensive effects on acute circulatory failure after heavy b |
治疗类型: | 补气药 |
TCM_ID_id: | 3861 |
SymMap_id: | 336 |
TCMSP_id: | 594 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000094 | choline | Choline chloride; choline hydroxide | C5H14NO+ | 104.17 g/mol | C[N+](C)(C)CCO |
| TCMBANKIN000446 | 5-heptadecylresorcinol | C23H40O2 | 348.6 g/mol | CCCCCCCCCCCCCCCCCC1=CC(=CC(=C1)O)O | |
| TCMBANKIN000532 | smiglaside b | CC(=O)OCC1C(C(C(C(O1)OC2(C(C(C(O2)COC(=O)C=CC3=CC(=C(C=C3)O)OC)O)OC(=O)C=CC4=CC(=C(C=C4)O)OC)COC(=O)C=CC5=CC(=C(C=C5)O)OC)OC(=O)C)O)O | |||
| TCMBANKIN000600 | 2,3,8-Trimethyldecane | C13H28 | 184.36 | CCC(C)CCCCC(C)C(C)C | |
| TCMBANKIN000734 | Ginsenoside-Rh3_qt | ginsenoside-Rh3_qt | C36H60O7 | 604.86 | |
| TCMBANKIN000962 | campesterol | campesterol ; FT-0082089; Augelicincampesterol; (24R)-5-Ergosten-3; (1R,3AS,3BR,9AS,9BS,11AR)-1-[(2R,5R)-5,6-DIMETHYLHEPTAN-2-YL]-9A,11A-DIMETHYL-1H,2H,3H,3AH,3BH,4H,5H,5AH,6H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-OL; A-ol; 24(R)-Ergost-5-en-3beta-ol; 24alpha-Methyl-5-cholesten-3beta-ol; AK307302; SC-66911; (8R,9S,10S,13R,14S,17R)-17-((2R,5R)-5,6-Dimethylheptan-2-yl)-10,13-dimethyl-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; AKOS027320474; MFCD00010475; Campesterin; MolPort-035-882-175 | C28H48O | 400.68 | CC(C)C(C)CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
| TCMBANKIN000977 | maltose | D4E2CF9C-C3A1-4AC1-A51E-A51162B6056D; WURCS=1.0/2,1/[X2122h; SCHEMBL9688735; 1,5][22122h; 1,5]1+1,2+4 | C12H22O11 | 342.3 g/mol | C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)O)O |
| TCMBANKIN000995 | Ramalic acid | ramalic acid; 2-hydroxy-4-(2-hydroxy-4-methoxy-3,6-dimethyl-benzoyl)oxy-6-methyl-benzoic acid; 2-hydroxy-4-[(2-hydroxy-4-methoxy-3,6-dimethylphenyl)-oxomethoxy]-6-methylbenzoic acid; Obtusatsaure; 2-hydroxy-4-(2-hydroxy-4-methoxy-3,6-dimethyl-phenyl)carbonyloxy-6-methyl-benzoic acid; AC1NSZZE; 500-37-8; ramalicacid; 2-hydroxy-4-(2-hydroxy-4-methoxy-3,6-dimethylbenzoyl)oxy-6-methylbenzoic acid | C18H18O7 | 346.33 | CC1=CC(=CC(=C1C(=O)O)O)OC(=O)C2=C(C(=C(C=C2C)OC)C)O |
| TCMBANKIN001388 | Ginsenoside-Rh4_qt | C36H60O8 | 620.86 | ||
| TCMBANKIN001766 | Smiglaside D | smiglaside d | 966.97 | CC(=O)OCC1C(C(C(C(O1)OC2(C(C(C(O2)COC(=O)C=CC3=CC(=C(C=C3)O)OC)O)OC(=O)C=CC4=CC(=C(C=C4)O)OC)COC(=O)C=CC5=CC=C(C=C5)O)OC(=O)C)O)OC(=O)C | |
| TCMBANKIN001815 | trifolin | LMPK12111663; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; Trifolin; C12626; MEGxp0_000499; Kaempferol 3-O-beta-D-galactoside; Kaempferol-3-O-galactoside; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; ACon1_000322; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one | C21H20O11 | 448.4 g/mol | C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O |
| TCMBANKIN001824 | Adenosine triphosphate | adenosine triphosphate; ZINC33974212 | C10H12N5O13P3-4 | 503.15 g/mol | C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O)O)N |
| TCMBANKIN002133 | Deoxyharringtonine | Cephalotaxine, 4-methyl-, 2-hydroxy-2-(3-methylbutyl)butanedioate (ester), (3(R))-; NSC 142196; Cephalotaxine, 4-methyl-2-hydroxy-2-(3-methylbutyl)butanedioate (ester), (3(R))- (9CI); deoxyharringtonine | C28H37NO8 | 515.6 | CC(C)CCC(CC(=O)OC)(C(=O)OC1C2C3=CC4=C(C=C3CCN5C2(CCC5)C=C1OC)OCO4)O |
| TCMBANKIN002350 | 20(s)-ginsenosiderh2 | 20(s)-ginsenoside-rh2 | C36H62O8 | 622.9 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C |
| TCMBANKIN002812 | notoginsenosider2 | notoginsenoside R2; notoginsenoside r2 | C41H70O13 | 771 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(CO6)O)O)O)C)O)C)O)C |
| TCMBANKIN002907 | guanosine | Guanosine, hydrate; s3068; CTK0F0492; Guanosine hydrate (1:1); 2-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,9-dihyd; YCHNAJLCEKPFHB-GWTDSMLYSA-N; Guanosine, hydrate (1:1); Z-4761; SCHEMBL555106; AK645793; 1143525-19-2; MolPort-003-935-435; guanosine-hydrate; AK607682; 2-Amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one hydrate(1:x); 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one hydrate; 2451AH; 294B1373-E8C3-442D-8240-D7EA2650B160; AKOS030573276; 141433-61-6; ro-6H-purin-6-one hydrate; 2-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,9-dihydro-6H-purin-6-one hydrate; Guanosine Hydrate; B3678 | C10H13N5O5 | 283.24 | C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(NC2=O)N |
| TCMBANKIN003119 | 12-O-Nicotinoylisolineolone | 12-o-nicotinoylisolineolone; AC1NSZ3Z; [(3S,8S,10R,12R,13S,14R,17S)-17-acetyl-3,8,14-trihydroxy-10,13-dimethyl-2,3,4,7,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-12-yl] pyridine-3-carboxylate | 469.63 | CC(=O)C1CCC2(C1(C(CC3C2(CC=C4C3(CCC(C4)O)C)O)OC(=O)C5=CN=CC=C5)C)O | |
| TCMBANKIN003143 | smiglaside a | CC(=O)OCC1C(C(C(C(O1)OC2(C(C(C(O2)COC(=O)C=CC3=CC(=C(C=C3)O)OC)O)OC(=O)C=CC4=CC(=C(C=C4)O)OC)COC(=O)C=CC5=CC(=C(C=C5)O)OC)OC(=O)C)O)OC(=O)C | |||
| TCMBANKIN003424 | Dauricine (8CI) | NSC 36413; Phenol, 4-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]-2-[4-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]phenoxy]-; AIDS-012035; 4-[[(1R)-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]methyl]-2-[4-[[(1R)-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]methyl]phenoxy]phenol; C09419; Phenol, 4-((1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl)methyl)-2-(4-((1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl)methyl)phenoxy)-, (R-(R*,R*))-; AIDS012035 | C35H60O6 | 576.85 | CN1CCC2=CC(=C(C=C2C1CC3=CC=C(C=C3)OC4=C(C=CC(=C4)CC5C6=CC(=C(C=C6CCN5C)OC)OC)O)OC)OC |
| TCMBANKIN003533 | Methylselenocysteine | (2R)-2-amino-3-methylselanylpropanoic acid; 2574-71-2; Lopac0_000799; (2R)-2-amino-3-methylselanyl-propanoic acid; (2R)-2-amino-3-(methylseleno)propanoic acid; C08293; 09974_FLUKA; CCRIS 5465; Selenium-methylselenocystine; Se-Methyl-L-selenocysteine; (2R)-2-amino-3-(methylseleno)propionic acid; 26046-90-2; Se-Methyl-seleno-L-cysteine; 3-(Methylseleno)-L-alanine; L-Alanine, 3-(methylseleno)-; (R)-2-Amino-3-(methylseleno)propionic acid | C4H9NO2Se | 182.08 | C[Se]CC(C(=O)O)N |
| TCMBANKIN003571 | MAL | Advanctose 100; Sunmalt; Finetose F; 77072-48-1; Maltose HH; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol; Cextromaltose; 5-17-07-00189 (Beilstein Handbook Reference); Maltose-b; 73824-72-3; alpha-D-glucopyranosyl-(1->4)-beta-D-glucopyranose; Finetose; 4-O-alpha-D-glucopyranosyl-beta-D-glucopyranose; AI3-09089; CHEBI:18147; BRN 0093798; 133-99-3; ZINC04095762; C01971; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-oxane-3,4,5-triol; Sunmalt S; Maltose (8CI); beta-D-glucopyranose, 4-O-alpha-D-glucopyranosyl-; D-Glucose, 4-O-alpha-D-glucopyranosyl- (6CI,9CI); (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)tetrahydropyran-3-yl]oxy-tetrahydropyran-3,4,5-triol; 4-(alpha-D-Glucopyranosido)-alpha-glucopyranose; D-Glucose, 4-O-alpha-D-glucopyranosyl-; EINECS 200-716-5; Maltose [JAN]; Maltose, pure; Maltodiose; alpha-D-Glcp-(1->4)-beta-D-Glcp; 4-(alpha-D-Glucosido)-D-glucose; D-Maltose; Advantose 100; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)-3-tetrahydropyranyl]oxy]tetrahydropyran-3,4,5-triol; D-(+)-Maltose; (2R,3S,4S,5R,6R)-2-methylol-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-methylol-tetrahydropyran-3-yl]oxy-tetrahydropyran-3,4,5-triol; Maltose HHH | C12H22O11 | 342.3 | C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)O)O |
| TCMBANKIN003805 | TDA | 91988_FLUKA; NSC 69131; 4-02-00-01117 (Beilstein Handbook Reference); NSC 25955; EINECS 211-341-1; T0502_SIGMA; (C10-C16)Alkylcarboxylic acid; EINECS 268-105-6; Tridecanoic acid; LMFA01010013; NSC69131; AI3-04166; 638-53-9; 68002-90-4; Fatty acids, C10-16; (C10-C16) Carboxylic acid; n-Tridecanoic acid; NCIOpen2_003250; WLN: QV12; n-Tridecoic acid; TRIDECYLIC ACID; CHEBI:45919; BRN 0508317; NSC25955 | C13H26O2 | 214.34 | CC1=C(C=C(C=C1)N)N |
| TCMBANKIN004799 | 20-(S)-Ginsenoside-Rg3_qt | C42H72O13 | 785.01 | ||
| TCMBANKIN005718 | tauremisin | (3S,3aS,5aR,9R,9aS,9bS)-9-hydroxy-3,5a,9-trimethyl-3,3a,4,5,9a,9b-hexahydrobenzo[g][1]benzofuran-2,6-dione; NCGC00247310-02; Tauremizin; AC1L3RU8; CTK8E0358; NCGC00247310-01; Eudesm-2-en-12-oic acid, 4,6-alpha-dihydroxy-1-oxo-, gamma-lactone, (11S)-; (3S,3aS,5aR,9R,9aS,9bS)-9-hydroxy-3,5a,9-trimethyl-3a,4,5,5a,9,9a-hexahydronaphtho[1,2-b]furan-2,6(3H,9bH)-dione; 34319-09-0; HMS2225C10; 3162-56-9; NCGC00247310-03_C15H20O4_(3S,3aS,5aR,9R,9aS,9bS)-9-Hydroxy-3,5a,9-trimethyl-3a,5,5a,9,9a,9b-hexahydronaphtho[1,2-b]furan-2,6(3H,4H)-dione; ZINC3881676; Barrelin; Judaicin (sesquiterpene); MLS001185447; 3a,5,5a,9,9a,9b-Hexahydro-9-hydroxy-3,5a,9-trimethylnaphtho(1,2-b)furan-2,6(3H,4H)-dione; Judaicin (eudesmane naphthofuran); MolPort-002-507-199; Vulgarin, >=90% (LC/MS-ELSD); LS-68583; MCULE-9439093573; BG00615162; C09600; Vulgarin; BBL034028; 17237-80-8; Naphtho(1,2-b)furan-2,6(3H,4H)-dione, 3a,5,5a,9,9a,9b-hexahydro-9-hydroxy-3,5a,9-trimethyl-, (3S,3aS,5aR,9R,9aS,9bS)-; (3s,3as,5ar,9r,9as,9bs)-9-hydroxy-3,5a,9-trimethyl-3a,5,5a,9,9a,9b-hexahydronaphtho[1,2-b]furan-2,6(3h,4h)-dione; Naphtho(1,2-b)furan-2,6(3H,4H)-dione, 3a,5,5a,9,9a,9b-hexahydro-9-hydroxy-3,5a,9-trimethyl-, (3S-(3alpha,3aalpha,5abeta,9alpha,9aalpha,9bbeta))-; BB_NC-0703; 1351-48-0; 5091/7/6; Tauremisin; Judaicin; SMR000445685; CHEMBL1422618; AKOS001483019; CHEBI:10024; (3aS,5aR,9R,9aS,9bS)-9-hydroxy-3,5a,9-trimethyl-3a,5,5a,9,9a,9b-hexahydronaphtho[1,2-b]furan-2,6(3H,4H)-dione; MCULE-3300544479; MLS000728573; STK013739 | C15H20O4 | 264.32 g/mol | CC1C2CCC3(C(C2OC1=O)C(C=CC3=O)(C)O)C |
| TCMBANKIN005938 | Suffruticoside A_qt1 | 302.26 | |||
| TCMBANKIN006014 | Malonylginsenoside Rc | malonylginsenosiderc; malonylginsenoside rc | 1165.48 | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)COC(=O)CC(=O)O)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(O8)CO)O)O)O)O)O)C | |
| TCMBANKIN006223 | Enhydrin | enhydrine; BDBM50377905; enhydrin; CHEMBL206765; D0J7XB | C23H28O10 | 464.46 | CC1C(O1)(C)C(=O)OC2C3C(C4C(O4)(CCC=C(C2OC(=O)C)C(=O)OC)C)OC(=O)C3=C |
| TCMBANKIN006703 | p-Glucosyloxymandelonitrile | p-glucosyloxymandelonitrile | C14H17NO7 | 311.29 g/mol | C1=CC(=CC=C1C(C#N)O)OC2C(C(C(C(O2)CO)O)O)O |
| TCMBANKIN006965 | D-erythro-Isocitric acid | 3-carboxy-2,3-dideoxy-D-erythro-pentaric acid; 30810-51-6; CHEBI:160; (1S,2S)-1-hydroxypropane-1,2,3-tricarboxylic acid; C04617 | C6H8O7 | 192.12 | C(C(C(C(=O)O)O)C(=O)O)C(=O)O |
| TCMBANKIN007012 | ginsenoside-Rh1_qt | 20(R)-Ginsenoside-Rh1_qt; ginsenoside- Rh1_qt; 20(R)-ginsenoside Rh1_qt | C36H62O9 | 638.87 | |
| TCMBANKIN007030 | 2,3,4-Trimethyldecane | C13H28 | 184.36 | CCCCCCC(C)C(C)C(C)C | |
| TCMBANKIN007092 | glucuronic acid | ZINC3869801; CHEBI:28860; glucuronicacid; C08350; (2S,3S,4S,5R,6R)-3,4,5,6-tetrahydroxytetrahydropyran-2-carboxylic acid; (2S,3S,4S,5R,6R)-3,4,5,6-tetrahydroxy-2-tetrahydropyrancarboxylic acid; BDP; beta-D-Glucuronic acid; (2S,3S,4S,5R,6R)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid; GCU; BETA-D-GALACTOPYRANURONIC ACID; beta-L-Altropyranuronic acid; beta-D-Glucopyranuronic acid; SCHEMBL15596882; BIG1006 | C6H10O7 | 194.14 | C1(C(C(OC(C1O)O)C(=O)O)O)O |
| TCMBANKIN007364 | Gypnoside V_qt | Ginsenoside-Ra2_qt; Gypenoside XI_qt; Ginsenoside-Rb3_qt; Gypenoside VII_qt; Gypenoside XII_qt; Ginsenoside-Ra0_qt; Dammarane Sapogenin; Gypenoside XVII_qt; Gypenoside IX_qt; Gypenoside LXXV_qt; Gypenoside LXIX_qt; Gypenoside XIX_qt; Gypenoside XV_qt; Gypenoside XIII_qt; Gypinoside III_qt; ginsenoside Rd2_qt; Notoginseoside Fe_qt; Gypenoside IV_qt; Ginsenoside-Rs2_qt; Ginsenoside-Rs1_qt; Gypenoside XVI_qt; Gypinoside VII_qt; Ginsenoside-Ra3_qt; Gypenoside II_qt; Ginsenoside-Ra1_qt; Gypenoside VI_qt | C53H90O22 | 1079.27 | |
| TCMBANKIN007831 | 4,7-Dihydroxy-5-methoxyl-6-methyl-8-formyl-flavan | 4,7-dihydroxy-5-methoxyl-6-methyl-8-formyl-flavan | C18H18O5 | 314.3 g/mol | CC1=C(C(=C2C(=C1OC)C(CC(O2)C3=CC=CC=C3)O)C=O)O |
| TCMBANKIN008834 | 6''-malonylginsenosiderd1 | ||||
| TCMBANKIN008923 | 20(S)-ginsenoside-Rg2 | C42H72O13 | 785.01 | CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CC4(C(CC(C5C4(CCC5C(C)(CCC=C(C)C)O)C)O)C6(C3C(C(CC6)O)(C)C)C)C)CO)O)O)O)O)O | |
| TCMBANKIN009545 | Argininyl-fructosyl-glucose | argininyl-fructosyl-glucose | C18H34N4O12 | 498.56 | C1C(C(C(C(O1)(CNC(CCCN=C(N)N)C(=O)O)O)O)OC2C(C(C(C(O2)CO)O)O)O)O |
| TCMBANKIN009594 | isocnidilide | C12H18O2 | 194.27 g/mol | CCCCC1C2CCCC=C2C(=O)O1 | |
| TCMBANKIN010119 | 7-Tetradecyne | SBB008952; tetradec-7-yne; 35216-11-6; 7-C14H26 | C14H26 | 194.36 | CCCCCCC#CCCCCCC |
| TCMBANKIN010207 | β-sitosterol-3-(6-palmito leoyl)glucopyranoside | C51H88O7 | |||
| TCMBANKIN010361 | 3-O-caffeoylshikimic acid | 3-o-caffeoylshikimic acid; 3-o-caffeoylshikimicacid | C16H16O8 | 336.29 g/mol | C1C(C(C(C=C1C(=O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)O)O |
| TCMBANKIN011390 | Methyl palmitelaidate | Methyl trans-9-hexadecenoate; (E)-9-Hexadecenoic acid, methyl ester; 76117_FLUKA; 10030-74-7; 9-Hexadecenoic acid, (E), methyl ester; (E)-hexadec-9-enoic acid methyl ester; P0203_SIGMA; Palmitelaidic acid methyl ester; hexadec-9-enoic acid methyl ester; methyl hexadec-9-enoate; methyl (E)-hexadec-9-enoate | C17H32O2 | 268.43 | CCCCCCC=CCCCCCCCC(=O)OC |
| TCMBANKIN011616 | oleanane | Oleanane | C30H52 | 412.73 | CC1(CCC2(CCC3(C(C2C1)CCC4C3(CCC5C4(CCCC5(C)C)C)C)C)C)C |
| TCMBANKIN012460 | Folinic acid | 4-{[(2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methyl]amino}-N-(1,3-dicobaltiopropyl)benzamide; folinic acid; N5 -Formyl-5,6,7,8- tetrahydropteroyl-L -glutamic acid; N5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid; folinicacid | C99H148N24O24S2 | 2122.51 | C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].O.O.O.O.O.[Ca+2] |
| TCMBANKIN013466 | 3,5-Dimethylbenzaldehyde | 518050_ALDRICH; ZINC04255603; Benzaldehyde, 3,5-dimethyl-; 5779-95-3 | C9H10O | 134.18 | CC1=CC(=CC(=C1)C=O)C |
| TCMBANKIN014313 | 13-Tetradecenyl acetate | tetradec-13-enyl ethanoate; acetic acid tetradec-13-enyl ester; tetradec-13-enyl acetate; 13-Tetradecen-1-ol acetate | C16H30O2 | 254.41 | CC(=O)OCCCCCCCCCCCCC=C |
| TCMBANKIN014618 | Campesteryl ferulate | campesteryl ferulate | C38H56O4 | 576.85 | CC(C)C(C)CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC(=O)C=CC5=CC(=C(C=C5)O)OC)C)C |
| TCMBANKIN015217 | quinquenosider1 | quinquenoside r 1 | C56H94O24 | 1151.3 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)COC(=O)C)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)C |
| TCMBANKIN015281 | Argininyl-fructosyl-glucose_qt | 336.4 | |||
| TCMBANKIN015460 | (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid | C47H74O18 | 927.08 | ||
| TCMBANKIN015759 | ginsenoside Rg5_qt | C42H70O12 | 767 | ||
| TCMBANKIN016720 | malkangunin | C24H32O7 | 432.51 | CC1CCC(C2(C13CC(C(C2OC(=O)C4=CC=CC=C4)OC(=O)C)C(O3)(C)C)CO)O | |
| TCMBANKIN016731 | arachidonate | CBiol_001948; KBio2_000511; KBio2_005395; Bio1_000234; SpecPlus_000727; 5,8,11,14-icosatetraenoate; Eicosanetetraenoic acid; (5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoic acid; AI3-09613; Spectrum4_000905; KBio2_003079; KBio3_000518; KBioSS_000511; KBio2_002827; CCRIS 6312; KBioSS_000259; (all-Z)-5,8,11,14-Eicosatetraenoic acid; 7771-44-0; Spectrum_000091; KBioGR_001370; Bio2_000739; CHEBI:36306; LMFA01030393; Bio1_001212; KBio2_000259; KBio1_001767; KBioGR_000259; Bio2_000259; 5,8,11,14-Eicosatetraenoic acid / 5,8,11,14-icosatetraenoic acid; KBio2_005647; 506-32-1; DivK1c_006823; Bio1_000723; KBio3_000517; arachidonic acid; EINECS 208-033-4; (5Z,8Z,11Z,14Z)-5,8,11,14-Eikosatetraensaeure; 5,8,11,14-Eicosatetraenoic acid, (all-Z)-; ARACHIDONIC_ACID; Icosa-5,8,11,14-tetraenoic acid | C20H32O2 | 304.47 | CCCCCC=CCC=CCC=CCC=CCCCC(=O)[O-] |
| TCMBANKIN017354 | (1S,4E,8E,10R)-4,8,11,11-tetramethylbicyclo[8.1.0]undeca-4,8-diene | C15H24 | 204.35 | ||
| TCMBANKIN017548 | (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2Z)-6-methylhepta-2,5-dien-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol | (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1Z)-1,5-dimethylhexa-1,4-dienyl]-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1Z)-1,5-dimethylhexa-1,4-dienyl]-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-methylol-tetrahydropyran-3,4,5-triol | C36H60O7 | 604.86 | CC(=CCC=C(C)C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)C |
| TCMBANKIN018324 | (3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol | (3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; (3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; (3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol | C42H72O14 | 801.01 | |
| TCMBANKIN018423 | 5 '-O-demethylhamatintine | ||||
| TCMBANKIN018531 | 20(s)-protopanaxadiol | (3S,8R,9R,10R,12R,13R,14S,17S)-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2R)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; AC1MIVF3; (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1R)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; 7755/1/3; (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1R)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol | C30H52O3 | 460.73 | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)O)C)C)O)C)O)C |
| TCMBANKIN019355 | Celabenzine | AC1NB02H; celabenzine; 9-benzoyl-2-phenyl-1,5,9-triazacyclotridecan-4-one | C23H29N3O2 | 379.5 | C1CCN(CCCNC(=O)CC(NC1)C2=CC=CC=C2)C(=O)C3=CC=CC=C3 |
| TCMBANKIN019381 | Pancratistatin | C08535; 96203-70-2; NCI60_003105; pancratistatin; SMP1_000217; NSC349156; NCIMech_000573; AC1O8OET; (1R,2S,3R,4R,4aS,11bR)-1,2,3,4,7-pentahydroxy-2,3,4,4a,5,11b-hexahydro-1H-[1,3]dioxolo[4,5-j]phenanthridin-6-one | C14H15NO8 | 325.27 | C1OC2=C(O1)C(=C3C(=C2)C4C(C(C(C(C4O)O)O)O)NC3=O)O |
| TCMBANKIN019433 | Pandamine | (2S,3S)-N-[(6S,9S,10R)-6-benzyl-2-hydroxy-5,8-dioxo-10-propan-2-yl-11-oxa-4,7-diazabicyclo[10.2.2]hexadeca-1(14),12,15-trien-9-yl]-2-(dimethylamino)-3-methylpentanamide; pandamine; AC1NSZFQ | C31H44N4O5 | 552.7 | CCC(C)C(C(=O)NC1C(OC2=CC=C(C=C2)C(CNC(=O)C(NC1=O)CC3=CC=CC=C3)O)C(C)C)N(C)C |
| TCMBANKIN019554 | Dianthoside | CHEMBL485278; maltol glucoside; SCHEMBL9986099; 2-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-pyran-4-one; maltol beta-D-glucopyranoside; MCULE-7230269274; dianthoside; 2-methyl-3-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-pyranone; NP-013538; 2-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypyran-4-one; 2-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-pyran-4-one; ZINC33830670; MolPort-019-937-019; AC1NSUGF; 20847-13-6; NCGC00385684-01_C12H16O8_4H-Pyran-4-one, 3-(beta-D-glucopyranosyloxy)-2-methyl-; 2-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-pyran-4-one; 2-METHYL-3-{[(2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL]OXY}PYRAN-4-ONE | C12H16O8 | 288.25 | CC1=C(C(=O)C=CO1)OC2C(C(C(C(O2)CO)O)O)O |
| TCMBANKIN020133 | Vulgarin | Tauremizin; Eudesm-2-en-12-oic acid, 4,6-alpha-dihydroxy-1-oxo-, gamma-lactone, (11S)-; 34319-09-0; 3162-56-9; (3S,3aS,5aR,9R,9aS,9bS)-9-hydroxy-3,5a,9-trimethyl-3,3a,4,5,9a,9b-hexahydrobenzo[g]benzofuran-2,6-dione; (3S,3aS,5aR,9R,9aS,9bS)-9-hydroxy-3,5a,9-trimethyl-3,3a,4,5,9a,9b-hexahydrobenzo[g]benzofuran-2,6-quinone; Barrelin; Judaicin (sesquiterpene); MLS001185447; 3a,5,5a,9,9a,9b-Hexahydro-9-hydroxy-3,5a,9-trimethylnaphtho(1,2-b)furan-2,6(3H,4H)-dione; ZINC03881676; 17237-80-8; C09600; Naphtho(1,2-b)furan-2,6(3H,4H)-dione, 3a,5,5a,9,9a,9b-hexahydro-9-hydroxy-3,5a,9-trimethyl-, (3S,3aS,5aR,9R,9aS,9bS)-; Naphtho(1,2-b)furan-2,6(3H,4H)-dione, 3a,5,5a,9,9a,9b-hexahydro-9-hydroxy-3,5a,9-trimethyl-, (3S-(3alpha,3aalpha,5abeta,9alpha,9aalpha,9bbeta))-; 1351-48-0; Tauremisin; Judaicin; SMR000445685; (3S,3aS,5aR,9R,9aS,9bS)-9-hydroxy-3,5a,9-trimethyl-3,3a,4,5,9a,9b-hexahydronaphtho[6,5-d]furan-2,6-dione; 5091-07-6; MLS000728573; STK013739 | C15H20O4 | 264.32 | CC1C2CCC3(C(C2OC1=O)C(C=CC3=O)(C)O)C |
| TCMBANKIN020564 | 2,6-di-tert-butyl-4-methy-phenol | ||||
| TCMBANKIN020751 | (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol | (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol | C53H90O22 | 1079.27 | |
| TCMBANKIN021134 | vitamin b15 | C20H40N2O8 | 436.5 g/mol | CC(C)N(C(C)C)C(C(=O)OCC(C(C(C(C(=O)O)O)O)O)O)N(C(C)C)C(C)C | |
| TCMBANKIN021214 | suchilactone | SCHEMBL15624884 | C21H20O6 | 368.38 | COC1=C(C=C(C=C1)CC2COC(=O)C2=CC3=CC4=C(C=C3)OCO4)OC |
| TCMBANKIN021390 | L-Adenosine | (2S,3S,4R,5S)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; AIDS047770; (2S,3S,4R,5S)-2-(6-aminopurin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol; (2S,3S,4R,5S)-2-(6-amino-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; AIDS-047770; Oprea1_180751; (2S,3S,4R,5S)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; (2S,3S,4R,5S)-2-(6-Amino-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol | C10H13N5O4 | 267.24 | C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N |
| TCMBANKIN021640 | ginsenoside Ro_qt | chikusetsusaponin Ⅳ_qt; chikusetsusaponinⅤ_qt; ginsenoside- Ro_qt; (3b)-3-hydroxy-Olean-12-en-28-oic acid, monosodium salt; Ginsenoside-R0_qt | C47H74O18 | 927.08 | |
| TCMBANKIN021708 | se-methyl-l-selenocysteine | Se-methylselenocysteine; Methylselenocysteine; Se-methyl-L-selenocysteine zwitterion; (2R)-2-ammonio-3-(methylselanyl)propanoate; CHEBI:58531 | C4H9NO2Se | 182.09 g/mol | C[Se]CC(C(=O)[O-])[NH3+] |
| TCMBANKIN022216 | (3R,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol | (3R,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; (3R,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; (3R,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol | C54H92O23 | 1109.29 | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)O)C)C)O)C)O)C |
| TCMBANKIN022337 | β-sitosterol-3-(6-stear oyl)glucopyranoside | ||||
| TCMBANKIN023219 | ginsenoside-la | beta-D-Glucopyranoside, (3beta,12beta,23R)-12,23-epoxydammar-24-ene-3,20-diyl bis-; 123617-34-5; VOUCMBDNXOKLCQ-YATHHJDDSA-N | C41H68O13 | 769 g/mol | CC(=CC1CC(C2CCC3(C2C(O1)CC4C3CCC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)CO)O)O)O)C)C)(C)OC7C(C(C(C(O7)CO)O)O)O)C |
| TCMBANKIN023371 | (1R,4S,4aR,8aR)-4-isopropyl-1,6-dimethyl-3,4,4a,7,8,8a-hexahydro-2H-naphthalen-1-ol | (1R,4S,4aR,8aR)-1,6-dimethyl-4-propan-2-yl-3,4,4a,7,8,8a-hexahydro-2H-naphthalen-1-ol | C15H26O | 222.37 | |
| TCMBANKIN023629 | 3-[[(2S)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoic acid | 3-[[(2S)-2,4-dihydroxy-3,3-dimethyl-1-oxobutyl]amino]propanoic acid; Prestwick1_000472; SPBio_002543; Prestwick0_000472; 3-[[(2S)-2,4-dihydroxy-3,3-dimethyl-butanoyl]amino]propanoic acid; Prestwick2_000472; 3-[[(2S)-2,4-dihydroxy-3,3-dimethyl-butanoyl]amino]propionic acid | C9H17NO5 | 219.24 | CC(C)(CO)C(C(=O)NCCC(=O)O)O |
| TCMBANKIN024983 | notoginsenosider4 | notoginsenoside r4; Notoginsenoside R4; AC1NSZ7O | C59H100O27 | 1241.59 | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)COC9C(C(C(C(O9)CO)O)O)O)O)O)O)O)O)O)C |
| TCMBANKIN025312 | tridecanoicacid | ACMC-209nix; D06YGT; DSSTox_GSID_21684; Tridecylate; CC-35306; 4-02-00-01117 (Beilstein Handbook Reference); NSC 25955; Tridecanoic acid, technical grade, 90%; C10-16 fatty acids; CTK1H1792; NCGC00248684-01; n-Tridecoate; n-Tridecanoic acid; NCIOpen2_003250; MFCD00002741; WLN: QV12; DSSTox_RID_76282; SZHOJFHSIKHZHA-UHFFFAOYSA-N; NSC25955; ZINC1628119; tridecoic acid; UNII-19936LIY2V; dodecylcarboxylic acid; 19936LIY2V; (S)-2-Aminotridecanoate; C-33591; n-Tridecanoate; NSC-25955; C13:0; (C10-C16)Alkylcarboxylic acid; 50354-80-8; AK126530; NSC69131; SCHEMBL22778; 638-53-9; KB-261156; 68002-90-4; Fatty acids, C10-16; (C10-C16) Carboxylic acid; tridecansäure; C17076; A834559; Tridecanoic acid, 98%; TL8004509; Medium-chain fatty acids, C10-16; AKOS009156483; NSC 69131; CAS-638-53-9; SCHEMBL1686771; tridecanoic acid (tridecylic acid); TR-021946; AX8155143; EINECS 211-341-1; 6131AF; AN-20449; LMFA01010013; tridecanoic acid; CHEMBL107874; DTXSID4021684; CDAA-N-13-A; BCE7320D-E579-415F-96F0-658E54E16CF0; n-Tridecoic acid; Tridecanoic acid, >=98%; LS-157146; Tridecylic acid; DSSTox_CID_1684; FT-0653520; SBB069518; MolPort-001-780-047; CS-D1510; Tridecanoic acid anion; Carboxylic acids, C10-16; S14-1033; NCGC00258091-01; NSC-69131; RTR-021946; EINECS 268-105-6; Tridecanoic acid, analytical standard; ANW-34759; AI3-04166; TRIDECANOIC ACID; Tox21_200537; CHEBI:45919; TRA0024554; BRN 0508317; C12-14 acid; AC1L1ZSI; DB02448 | C13H26O2 | 214.34 g/mol | CCCCCCCCCCCCC(=O)O |
| TCMBANKIN025437 | 2-methyl-tetradecane | C15H32 | 212.41 | CCCCCCCCCCCCC(C)C | |
| TCMBANKIN025505 | tartaric acid | tartaricacid; LS-188035 | C4H6O6 | 150.09 g/mol | C(C(C(=O)O)O)(C(=O)O)O |
| TCMBANKIN025752 | ginsenoside La_qt | Ginsenoside-La_qt | C42H70O13 | 783 | |
| TCMBANKIN025828 | stigmasterol-3-(6-stearoyl)glucopyranoside | ||||
| TCMBANKIN025846 | Mycosinol | AC1NQY4E; (3E)-3-hexa-2,4-diynylidene-4,9-dioxaspiro[4.4]nona-1,7-dien-6-ol; (2E)-2-hexa-2,4-diynylidene-1,6-dioxaspiro[4.4]nona-3,7-dien-9-ol; (2E)-2-Hexa-2,4-diynylidene-1,6-dioxaspiro(4.4)nona-3,7-dien-9-ol; NSC-653382; mycosinol; 111768-19-5; CHEBI:7038; C08455; NSC653382; CHEMBL1968944 | C13H10O3 | 214.22 | CC#CC#CC=C1C=CC2(O1)C(C=CO2)O |
| TCMBANKIN025919 | PANGAMIC ACID | 14513-57-6; (2R,3S,4R,5R)-6-[2,2-bis(diisopropylamino)-1-oxoethoxy]-2,3,4,5-tetrahydroxyhexanoic acid; 6-(Bis(bis(isopropyl)amino)acetate)-D-gluconic acid; (2R,3S,4R,5R)-6-[2,2-bis(di(propan-2-yl)amino)acetyl]oxy-2,3,4,5-tetrahydroxyhexanoic acid; 13149-69-4; D-Gluconic acid, 6-(bis(1-methylethyl)amino)acetate); Dimethyl-amino-acetylgluconic acid; (2R,3S,4R,5R)-6-[2,2-bis(diisopropylamino)acetyl]oxy-2,3,4,5-tetrahydroxy-hexanoic acid; (2R,3S,4R,5R)-6-[2,2-bis(di(propan-2-yl)amino)ethanoyloxy]-2,3,4,5-tetrahydroxy-hexanoic acid; EINECS 236-088-4; Kyselina pangamova [Czech]; Gluconic acid, 6-(bis(diisopropylamino)acetate) | C20H40N2O8 | 436.54 | CC(C)N(C(C)C)C(C(=O)OCC(C(C(C(C(=O)O)O)O)O)O)N(C(C)C)C(C)C |
| TCMBANKIN026213 | (2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,1 | (2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-oxan-2-yl]oxy-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,; (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-methylol-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,; (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-12-hydroxy-4,4,8,10,14-pentamethyl-2,; (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-[[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-2-tetrahydropyranyl]oxy]-12-hydroxy-4,4,8,10,14-pentamethyl | C48H82O18 | 947.15 | |
| TCMBANKIN026916 | 2-METHYLTRIDECANE | 1560-96-9; Tridecane, 2-methyl- | C14H30 | 198.39 | CCCCCCCCCCCC(C)C |
| TCMBANKIN026987 | N-Salicylidene-salicylamine | n-salicylidene-salicylamine | 227.28 | ||
| TCMBANKIN027148 | smilagenin | EINECS 204-775-8; CHEBI:28933; (25R)-Spirostane-3beta-ol; C08913; 5beta-Spirostan-3beta-ol, (25R)- (8CI); (25R)-Spirostan-3.beta.-ol; Isosarsasapogenin; Spirostan-3-ol, (3.beta.,5.beta.,25R)-; Spirostan-3-ol, (3beta,5beta,25R)- (9CI); NSC93747; NSC 93747; (25R)-5beta-Spirostan-3beta-ol; SMP1_000275; SCHEMBL180193; AI3-44895; Isosarsapogenin; (25R)-Spirostan-3beta-ol; 126-18-1; Smilagenin; 5.beta.-Spirostan-3.beta.-ol, (25R)- | C27H44O3 | 416.6 g/mol | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)O)C)C)C)OC1 |
| TCMBANKIN027228 | (+)-Maalioxide | (-)-Maalioxide; 2H-Naphtho(1,8-bc)furan, decahydro-2,2,5a,8a-tetramethyl-, (2aS-(2aalpha,5aalpha,8aalpha,8bbeta))-; 53625-18-6; (+)-maalioxide | C15H26O | 222.37 | CC1(C2CCCC3(C2C(O1)(CCC3)C)C)C |
| TCMBANKIN028392 | Smiglaside E | [(2S,3S,4R,5R)-2-[(2R,3R,4S,5S,6R)-3-acetyloxy-6-(acetyloxymethyl)-4,5-dihydroxy-oxan-2-yl]oxy-4-hydroxy-5-[[(E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoyl]oxymethyl]-2-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxymethyl]oxolan-3-yl] (E)-3-(4-hydroxy-3-methox; Simiglaside E; (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid [(2S,3S,4R,5R)-2-[[(2R,3R,4S,5S,6R)-3-acetoxy-6-(acetoxymethyl)-4,5-dihydroxy-2-tetrahydropyranyl]oxy]-4-hydroxy-5-[[(E)-3-(4-hydroxy-3-methoxyphenyl)-1-oxoprop-2-enoxy]methyl]-2-[[(E)-3-(4-hydroxyphenyl); [(2S,3S,4R,5R)-2-[(2R,3R,4S,5S,6R)-3-acetoxy-6-(acetoxymethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-4-hydroxy-5-[[(E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoyl]oxymethyl]-2-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxymethyl]tetrahydrofuran-3-yl] (E)-3-(4-; smiglaside e; [(2S,3S,4R,5R)-2-[(2R,3R,4S,5S,6R)-3-acetyloxy-6-(acetyloxymethyl)-4,5-dihydroxyoxan-2-yl]oxy-4-hydroxy-5-[[(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxymethyl]-2-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxymethyl]oxolan-3-yl] (E)-3-(4-hydroxy-3-methoxyp; (E)-3-(4-hydroxy-3-methoxy-phenyl)acrylic acid [(2S,3S,4R,5R)-2-[(2R,3R,4S,5S,6R)-3-acetoxy-6-(acetoxymethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-4-hydroxy-5-[[(E)-3-(4-hydroxy-3-methoxy-phenyl)acryloyl]oxymethyl]-2-[[(E)-3-(4-hydroxyphenyl)acryloyl]ox | C45H48O21 | 924.8 g/mol | CC(=O)OCC1C(C(C(C(O1)OC2(C(C(C(O2)COC(=O)C=CC3=CC(=C(C=C3)O)OC)O)OC(=O)C=CC4=CC(=C(C=C4)O)OC)COC(=O)C=CC5=CC=C(C=C5)O)OC(=O)C)O)O |
| TCMBANKIN028496 | 7,6'-dihydroxy-3'-methoxyisoflavone | AC1NSUOG; SCHEMBL9992779; 7-hydroxy-3-(2-hydroxy-5-methoxyphenyl)chromen-4-one | C16H12O5 | 284.26 g/mol | COC1=CC(=C(C=C1)O)C2=COC3=C(C2=O)C=CC(=C3)O |
| TCMBANKIN028621 | 6'-Malonylginsenoside Rd1 | 1195.51 | |||
| TCMBANKIN028660 | suffruticoside a | Suffruticoside A | C27H32O16 | 612.5 g/mol | CC(=O)C1=C(C=C(C=C1)OC)OC2C(C(C(C(O2)COC3C(C(CO3)(COC(=O)C4=CC(=C(C(=C4)O)O)O)O)O)O)O)O |
| TCMBANKIN028735 | vitamin b12 | C63H88CoN14O14P | 1355.4 g/mol | CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3] | |
| TCMBANKIN029207 | Ginsenoyne C | AC1NSVVW; LMFA05000662; ginsenoyne c; heptadeca-1,16-dien-4,6-diyne-3,9,10-triol | C17H24O3 | 276.37 | C=CCCCCCC(C(CC#CC#CC(C=C)O)O)O |
| TCMBANKIN029548 | [(3S,4R,5R)-5-[[(2R,3S,4S,5R,6S)-6-(2-acetyl-5-methoxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methoxy]-3,4-dihydroxyoxolan-3-yl]methyl 3,4,5-trihydroxybenzoate | [(3S,4R,5R)-5-[[(2R,3S,4S,5R,6S)-6-(2-ethanoyl-5-methoxy-phenoxy)-3,4,5-trihydroxy-oxan-2-yl]methoxy]-3,4-dihydroxy-oxolan-3-yl]methyl 3,4,5-trihydroxybenzoate; [(3S,4R,5R)-5-[[(2R,3S,4S,5R,6S)-6-(2-acetyl-5-methoxy-phenoxy)-3,4,5-trihydroxy-tetrahydropyran-2-yl]methoxy]-3,4-dihydroxy-tetrahydrofuran-3-yl]methyl 3,4,5-trihydroxybenzoate; 3,4,5-trihydroxybenzoic acid [(3S,4R,5R)-5-[[(2R,3S,4S,5R,6S)-6-(2-acetyl-5-methoxyphenoxy)-3,4,5-trihydroxy-2-tetrahydropyranyl]methoxy]-3,4-dihydroxy-3-tetrahydrofuranyl]methyl ester; 3,4,5-trihydroxybenzoic acid [(3S,4R,5R)-5-[[(2R,3S,4S,5R,6S)-6-(2-acetyl-5-methoxy-phenoxy)-3,4,5-trihydroxy-tetrahydropyran-2-yl]methoxy]-3,4-dihydroxy-tetrahydrofuran-3-yl]methyl ester | C27H32O16 | 612.53 | |
| TCMBANKIN029566 | Ginsenoyne B | 10-chloroheptadeca-1,16-dien-4,6-diyne-3,9-diol; ginsenoyne b; AC1NSVVT | C17H23ClO2 | 294.82 | C=CCCCCCC(C(CC#CC#CC(C=C)O)O)Cl |
| TCMBANKIN029647 | putrescine | 2-Butynedinitrile; Spectrum2_001935; NSC5861; Tetramethyldiamine; PUTRESCINE; KBio2_007262; Lopac-P-7505; AC1NS0M0; KBio2_004694; Sous-azote de carbone [French]; 1,4-Diamino-n-butane; NCGC00015837-01; SCHEMBL313163; CHEMBL1255652; KBio1_000716; 2-Butynedinitrile (9CI); InChI=1/C4H12N2/c5-3-1-2-4-6/h1-6H; ACETYLENEDICARBONITRILE; PUT; 32791_FLUKA; NINDS_000716; Spectrum_001646; KBio3_002375; Putrescin; BSPBio_002875; 4-aminobutylamine; D13208_ALDRICH; 333-93-7 (DIHYDROCHLORIDE); ZERO/005579; 1,4-butanediamine; .alpha.,.omega.-Butanediamine; Putreszin; A821757; CCRIS 6751; Spectrum3_001198; SDCCGMLS-0066929.P001; ZINC02039983; AI3-25444; Lopac0_000972; AIDS081098; 1071-98-3; 1,4-diaminobutane; but-2-ynedinitrile; VZ34178; Dicyanoacetylene; H2N(CH2)4NH2; Dicyanoethyne; IDI1_000716; butane-1,4-diamine; Butylenediamine; NCGC00180885-01; BRN 0605282; 32790_FLUKA; 4-04-00-01283 (Beilstein Handbook Reference); BUTANE,1,4-DIAMINO; KBioSS_002126; butane-1,4-diamine hydrochloride; KBioGR_000933; 1,4-Butylenediamine; 1,4-Tetramethylenediamine; Spectrum5_001005; CHEBI:17148; NSC-5861; SPBio_001969; NSC60545; alpha,omega-Diamine; KBio2_002126; C02896; 110-60-1; C00134; tetramethylenediamine; AIDS-081098; DivK1c_000716; Spectrum4_000237; EINECS 203-782-3; NCI60_004431; BRN 1735267; NSC 60545 | C4N2 | 76.06 | C(CCN)CN |
| TCMBANKIN029942 | Smiglaside C | (E)-3-(4-hydroxy-3-methoxy-phenyl)acrylic acid [(2S,3S,4R,5R)-2-[(2R,3R,4S,5S,6R)-3,5-diacetoxy-6-(acetoxymethyl)-4-hydroxy-tetrahydropyran-2-yl]oxy-4-hydroxy-5-[[(E)-3-(4-hydroxy-3-methoxy-phenyl)acryloyl]oxymethyl]-2-methylol-tetrahydrofuran-3-yl] ester; (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid [(2S,3S,4R,5R)-2-[[(2R,3R,4S,5S,6R)-3,5-diacetoxy-6-(acetoxymethyl)-4-hydroxy-2-tetrahydropyranyl]oxy]-4-hydroxy-5-[[(E)-3-(4-hydroxy-3-methoxyphenyl)-1-oxoprop-2-enoxy]methyl]-2-(hydroxymethyl)-3-tetrahy; Simiglaside C; [(2S,3S,4R,5R)-2-[(2R,3R,4S,5S,6R)-3,5-diacetyloxy-6-(acetyloxymethyl)-4-hydroxyoxan-2-yl]oxy-4-hydroxy-5-[[(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxymethyl]-2-(hydroxymethyl)oxolan-3-yl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; [(2S,3S,4R,5R)-2-[(2R,3R,4S,5S,6R)-3,5-diacetyloxy-6-(acetyloxymethyl)-4-hydroxy-oxan-2-yl]oxy-4-hydroxy-5-[[(E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoyl]oxymethyl]-2-(hydroxymethyl)oxolan-3-yl] (E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoate; smiglaside c; [(2S,3S,4R,5R)-2-[(2R,3R,4S,5S,6R)-3,5-diacetoxy-6-(acetoxymethyl)-4-hydroxy-tetrahydropyran-2-yl]oxy-4-hydroxy-5-[[(E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoyl]oxymethyl]-2-(hydroxymethyl)tetrahydrofuran-3-yl] (E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-e | C38H44O20 | 820.7 g/mol | CC(=O)OCC1C(C(C(C(O1)OC2(C(C(C(O2)COC(=O)C=CC3=CC(=C(C=C3)O)OC)O)OC(=O)C=CC4=CC(=C(C=C4)O)OC)CO)OC(=O)C)O)OC(=O)C |
| TCMBANKIN030197 | NN-Dimethyldecanamide | N,N-Dimethylcapramide; SBB008016; N,N-Dimethylcapylamide; N,N-Dimethyldecanamide; DECANAMIDE, N,N-DIMETHYL-; FR-0759; BRN 1906042; N,N-Dimethyldecanoamide; N,N-Dimethyldecan-1-amide; AI3-34960; EINECS 238-405-1; NSC 131411; 14433-76-2; NSC131411; WLN: 9VN1&1 | C12H25NO | 199.33 | CCCCCCCCCC(=O)N(C)C |
| TCMBANKIN030285 | vitamin b5 | 3-[[(2R)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoate; PANTOTHENIC ACID(d) Na salt; CHEBI:29032; GHOKWGTUZJEAQD-ZETCQYMHSA-M; CJ-15891; pantothenate; 3-[(2R)-2,4-dihydroxy-3,3-dimethylbutanamido]propanoate; 137-08-6; AB00375056_03; 20938-62-9; N-[(R)-2,4-Dihydroxy-3,3-dimethyl-1-oxobutyl]-beta-alanine anion; NCGC00183031-01; AC1Q5P1E; CTK1A3579; (+)-Pantothenate; AC1L50WB; 3bex; (R)-N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-beta-alanine, ion(1-); beta-Alanine, N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, ion(1-), (R)-; (R)-pantothenate | C9H16NO5- | 218.23 g/mol | CC(C)(CO)C(C(=O)NCCC(=O)[O-])O |
| TCMBANKIN030287 | Dianthramine | C08478; 2-[(2-carboxy-5-hydroxyphenyl)amino]-4-hydroxybenzoic acid; CHEBI:4492; 136945-65-8; 2-[(2-carboxy-5-hydroxy-phenyl)amino]-4-hydroxy-benzoic acid; AC1L9BBP; 2-(2-carboxy-5-hydroxyanilino)-4-hydroxybenzoic acid; 2-(2-carboxy-5-hydroxy-anilino)-4-hydroxy-benzoic acid; DTXSID30331591; 2,2'-Iminobis(4-hydroxybenzoic acid); dianthramine | C14H11NO6 | 289.24 | C1=CC(=C(C=C1O)NC2=C(C=CC(=C2)O)C(=O)O)C(=O)O |
| TCMBANKIN030311 | ginsenoside rb0 | ||||
| TCMBANKIN030322 | biotin | C10H16N2O3S | 244.31 g/mol | C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2 | |
| TCMBANKIN030794 | 6""-malonylginsenoside rd1 | ||||
| TCMBANKIN030912 | Chrysanthemaxanthin | .beta.,.epsilon.-Carotene-3,3'-diol, 5,8-epoxy-5,8-dihydro-, (3S,3'R,5R,6'R,8S)-; JRHJXXLCNATYLS-OMSIYMKDSA-N; .beta.,.epsilon.-Carotene-3,3'-diol, 5,8-epoxy-5,8-dihydro-; 2-[(2E,4E,6E,8E,10E,12E,14E,16E)-17-(4-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl)-6,11,15-trimethylheptadeca-2,4,6,8,10,12,14,16-octaen-2-yl]-4,4,7a-trimethyl-2,5,6,7-tetrahydro-1-benzofuran-6-ol; .alpha.-Carotene-3,3'-diol, 5,8-epoxy-5,8-dihydro-; Chrysanthemaxanthin, all-trans-; 2-[(1E,3E,5E,7E,9E,11E,13E,15E)-16-(4-Hydroxy-2,6,6-trimethyl-2-cyclohexen-1-yl)-1,5,10,14-tetramethyl-1,3,5,7,9,11,13,15-hexadecaoctaenyl]-4,4,7a-trimethyl-2,4,5,6,7,7a-hexahydro-1-benzofuran-6-ol #; AC1NTA37; chrysanthemaxanthin; .alpha.-Carotene-3,3'-diol, 5,8-epoxy-5,8-dihydro-, all-trans- | C14H21NO4 | 267.32 | CC1=CC(CC(C1C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C2C=C3C(CC(CC3(O2)C)O)(C)C)C)C)(C)C)O |
| TCMBANKIN031034 | methyl (Z)-icos-11-enoate | (Z)-icos-11-enoic acid methyl ester; 11-Eicosenoic acid, methyl ester, (Z)-; E6885_SIGMA; 17263_FLUKA; Methyl cis-11-eicosenoate; cis-11-Eicosenoic acid, methyl ester; cis-11-Eicosenoic acid methyl ester | C21H40O2 | 324.5 g/mol | CCCCCCCCC=CCCCCCCCCCC(=O)OC |
| TCMBANKIN031037 | Neohexane | 39740_FLUKA; 75-83-2; CCRIS 6019; AI3-16043; EINECS 200-906-8; D151408_ALDRICH; NCGC00091659-01; Butane, 2,2-dimethyl-; 2,2-Dimethylbutane; 39730_FLUKA; WLN: 2X1&1&1; HSDB 75; InChI=1/C6H14/c1-5-6(2,3)4/h5H2,1-4H; NSC74126; NSC 74126 | C6H14 | 86.18 | CCC(C)(C)C |
| TCMBANKIN031375 | Sodium tauropythocholate | sodium 2-[4-(3,12,16-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoylamino]ethanesulfonate; sodium tauropythocholate; AC1NT0G9 | C26H44NNaO7S | 514.78 | CC(CCC(=O)NCCS(=O)(=O)[O-])C1C(CC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C)O.[Na+] |
| TCMBANKIN032117 | (1R,4E,7E,11R)-1,5,9,9-tetramethyl-12-oxabicyclo[9.1.0]dodeca-4,7-diene | C15H24O | 220.35 | ||
| TCMBANKIN032287 | notoginsenoside R2_qt | Notoginsenoside R6_qt | C41H70O13 | 770.99 | |
| TCMBANKIN033040 | 6-malonylgypenoside v | C56H92O26 | |||
| TCMBANKIN033148 | panacon | AC1O3DSS; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(3S,8R,10R,12R)-12-hydroxy-4,4,8,10,14-pentamethyl-17-(2,6,6-trimethyloxan-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol | CC1(CCCC(O1)(C)C2CCC3(C2C(CC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)C | ||
| TCMBANKIN033299 | Ginsenoside-Rg3_qt | 20(R)-Ginsenoside Rg3_qt; ginsenoside- Rg3_qt; ginsenoside-Rg3_qt; Chikusetsusaponin Ia_qt; ginsenoside Rg3_qt; Ginsenoside Rg3_qt | C42H72O13 | 785.01 | |
| TCMBANKIN033400 | 5-isopentenyloxy-7-methoxycoumarin | C15H16O4 | CC(=CCOC1=C2C=CC(=O)OC2=CC(=C1)OC)C | ||
| TCMBANKIN033702 | citric acid | InChI=1/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12; NCGC00090954-02; NCGC00090954-01; HSDB 911; CIT; Citric acid (8CI); BRN 0782061; NCIStruc2_000099; 27109_RIEDEL; AIDS-017733; 1,2,3-PROPANETRICARBOXYLIC ACID,2-HYDROXY (CITRIC ACID); citr; 27488_FLUKA; FEMA No. 2306; E 330; 27485_FLUKA; 27487_FLUKA; 77-92-9; C2404_SIGMA; 2-Hydroxytricarballylic acid; NCIOpen2_004502; F 0001 (polycarboxylic acid); EPA Pesticide Chemical Code 021801; AI3-06286; 245654-34-6; 1,2,3-Propanetricarboxylic acid, 2-hydroxy-; Citretten; Kyselina citronova; 2-hydroxypropane-1,2,3-tricarboxylic acid; Anhydrous citric acid; Citrate standard for IC; C83155_SIAL; LS-2418; WLN: QV1XQVQ1VQ; 1,2,3-Propanetricarboxylic acid, 2-hydroxy- (9CI); NSC30279; .beta.-Hydroxytricarballylic acid; NSC 626579; FLC; NCI60_022579; LS-3185; 2-hydroxy-1,2,3-propanetricarboxylic acid; Caswell No. 221C; EINECS 201-069-1; 43136-35-2; 251275_SIAL; 38730_FLUKA; C4540_SIGMA; FEMA Number 2306; 4-03-00-01272 (Beilstein Handbook Reference); 3-Carboxy-3-hydroxypentane-1,5-dioic acid; Citric acid anhydrous (JAN); C00158; 12262-73-6; 240621_ALDRICH; AIDS017733; MLS001066346; Kyselina 2-hydroxy-1,2,3-propantrikarbonova [Czech]; 2-Hydroxypropanetricarboxylic acid; CCRIS 3292; KBio3_002740; NSC626579; D00037; SBB008922; Kyselina citronova [Czech]; Aciletten; NSC 30279; Anhydrous citric acid (JP15); 46933_SUPELCO; NCIOpen2_004062; Citric acid solution; CHEBI:30769; Citro; BSPBio_003240; NCIStruc1_000057; Uro-trainer; Citric acid, anhydrous (USP); W230618_ALDRICH; Citric acid [USAN:JAN]; H3cit; Chemfill; Hydrocerol A; Suby G; Oprea1_502996; Citric acid, anhydrous; SMR000471840; Citric acid anhydrous; Spectrum3_001850 | C6H8O7 | 192.12 | C(C(=O)O)C(CC(=O)O)(C(=O)O)O |
| TCMBANKIN033879 | panaxatriol | (3beta,6alpha,12beta,20R)-20,25-Epoxydammarane-3,6,12-triol; Panaxatriol; UPCMLD-DP046:002; SR-05000002178-2; 32791-84-7; (20S)-Panaxatriol; NSC 308880; SR-05000002178; NCGC00161615-01; (3S,5R,6R,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-pentamethyl-17-[(2R)-2,6,6-trimethyltetrahydropyran-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; AIDS031251; MolPort-039-338-080; Dammarane-3,6,12-triol, 20,25-epoxy-, (3.beta.,6.beta.,12.beta.,20R)-; CCG-208596; AIDS-031251; UPCMLD-DP046:001; Ambotz32791-84-7; ZINC17654227; UPCMLD-DP046; (3S,5R,6R,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-pentamethyl-17-[(2R)-2,6,6-trimethyloxan-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; (3S,5R,6R,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-pentamethyl-17-[(2R)-2,6,6-trimethyl-2-tetrahydropyranyl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; CHEMBL1357750 | C30H52O4 | 476.73 | CC1(CCCC(O1)(C)C2CCC3(C2C(CC4C3(CC(C5C4(CCC(C5(C)C)O)C)O)C)O)C)C |
| TCMBANKIN033935 | Malonylginsenoside Rd_qt | Malonylginsenoside Rd_qt1 | 460.82 | ||
| TCMBANKIN033991 | 3-O-beta-D-Glucuronopyranosyl gypsogenin_qt | 470.76 | |||
| TCMBANKIN034097 | 20(S)-Ginsenoside-Rh1_qt | 20(R)-ginsenoside Rg2_qt; 20-(R)-Ginsenoside-Rg2_qt | C42H72O13 | 785.01 | |
| TCMBANKIN034575 | Inermin | C16229; (+)-Maackiain; 6H-(1,3)Dioxolo(5,6)benzofuro(3,2-c)(1)benzopyran-3-ol, 6a,12a-dihydro-, cis-(+-)-; 38822-02-5; 6a,12a-Dihydro-6H-(1,3)dioxolo(5,6)benzofuro(3,2-c)(1)benzopyran-3-ol; 19908-48-6 | C16H12O5 | 284.26 | C1C2C(C3=C(O1)C=C(C=C3)O)OC4=CC5=C(C=C24)OCO5 |
| TCMBANKIN035035 | epsilon-Cadinene | AC1NST8E; (4aR)-4,7-dimethylidene-1-propan-2-yl-1,2,3,4a,5,6,8,8a-octahydronaphthalene; epsilon-cadinene | C15H24 | 204.35 g/mol | CC(C)C1CCC(=C)C2C1CC(=C)CC2 |
| TCMBANKIN035363 | 5-METHYLTETRALIN | 2809-64-5; Naphthalene, 1,2,3,4-tetrahydro-5-methyl-; InChI=1/C11H14/c1-9-5-4-7-10-6-2-3-8-11(9)10/h4-5,7H,2-3,6,8H2,1H; 5-methyl-1,2,3,4-tetrahydronaphthalene | C11H14 | 146.23 | CC1=C2CCCCC2=CC=C1 |
| TCMBANKIN035440 | dauricine | AKOS015965146; AC-20217; SCHEMBL677474; 524-17-4 | C38H44N2O6 | 624.77 | CN1CCC2=CC(=C(C=C2C1CC3=CC=C(C=C3)OC4=C(C=CC(=C4)CC5C6=CC(=C(C=C6CCN5C)OC)OC)O)OC)OC |
| TCMBANKIN035818 | Ginsenoyne A | 139163-34-1; AC1NSVVQ; ginsenoyne a; 8-[3-(hept-6-en-1-yl)oxiran-2-yl]oct-1-en-4,6-diyn-3-ol; 8-(3-hept-6-enyloxiran-2-yl)oct-1-en-4,6-diyn-3-ol; 9,10-Epoxy-1,16-heptadecadiene-4,6-diyn-3-ol; LMFA05000661 | C17H22O2 | 258.36 | C=CCCCCCC1C(O1)CC#CC#CC(C=C)O |
| TCMBANKIN036079 | Malonylginsenoside Rc_qt1 | 460.82 | |||
| TCMBANKIN036312 | 20-Hexadecanoylingenol | 20-hexadecanoylingenol | C36H58O6 | 586.94 | CCCCCCCCCCCCCCCC(=O)OCC1=CC2C3C(C3(C)C)CC(C4(C2=O)C=C(C(C4(C1O)O)O)C)C |
| TCMBANKIN036503 | alexandrin_qt | daucosterin_qt | C35H60O6 | 576.85 | |
| TCMBANKIN036872 | ginsenoside Rh2 | ginsenoside-rh2; 78214-33-2; (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-tri; (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-methylol-tetrahydropyran-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-tr; beta-D-Glucopyranoside, (3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl; ginsenoside rh 2; Ginsenoside Rg3 metabolite; ginsenoside rh-2 | C36H62O8 | 623 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](O[H])(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])( [H])C2([H])[H])[C@@]23C([H])([H])[H])[C@@]3(C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]4([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[C@@]5([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])( O[H])[C@@]5([H])O[H] |
| TCMBANKIN036873 | Ginsenoside Rd | ginsenoside-rd; ginsenosiderd; A829210; 2-(hydroxymethyl)-6-[6-(hydroxymethyl)-2-[[17-[2-[6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-3,12-bis(oxidanyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-b; 2-[[2-[[3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[6-methyl-2-[[3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]hept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)-3-oxanyl]oxy]-6 | 947 | ||
| TCMBANKIN036885 | protopanaxadiol | C30H52O3 | 460.7 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)O)C)C)O)C)O)C | |
| TCMBANKIN036909 | Notoginsenoside R1 | A839906; notoginsenosider1; notoginsenoside r1 ; 2-(hydroxymethyl)-6-[2-[6-[6-(hydroxymethyl)-3-methyl-4,5-bis(oxidanyl)oxan-2-yl]oxy-4,4,8,10,14-pentamethyl-3,12-bis(oxidanyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-hept-5-en-2-yl]oxy-oxane-3,4,5-triol; oxa; (2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahyd; 80418-24-2; (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-methylol-3-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15; (2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-oxan-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahy; C08961; 2-[2-[6-[[4,5-dihydroxy-6-(hydroxymethyl)-3-methyl-2-oxanyl]oxy]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; oxane-2,3,4; (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[[(2S,3R,4S,5R)-3,4,5-trihydroxy-2-tetrahydropyranyl]oxy]-2-tetrahydropyranyl]oxy]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,1; (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,1; Notoginsenoside R1 | C47H80O18 | 933 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](C([H])([H])[H])(C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])O[C@@]2([H]) O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])[C@@]5([H])O[C@@]6([H])O[C@]([H])(C([H])([H])O[H] )[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]6([H])O[C@@]7([H])OC([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]7([H])O[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[H] |
| TCMBANKIN037001 | alpha-Guaiene | (1S,4S,7R)-1,4-dimethyl-7-prop-1-en-2-yl-1,2,3,4,5,6,7,8-octahydroazulene; alpha-guaiene; α-guaiene; (1S,4S,7R)-7-isopropenyl-1,4-dimethyl-1,2,3,4,5,6,7,8-octahydroazulene | C15H24 | 204.35 g/mol | CC1CCC(CC2=C1CCC2C)C(=C)C |
| TCMBANKIN037412 | Dammarane | (5S,8R,9R,10S,13R,14S,17R)-17-[(1R)-1,5-dimethylhexyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene; (5S,8R,9R,10S,13R,14S,17R)-4,4,8,10,14-pentamethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene; 545-22-2 | C30H54 | 414.75 | CC(C)CCCC(C)C1CCC2(C1CCC3C2(CCC4C3(CCCC4(C)C)C)C)C |
| TCMBANKIN037440 | Uridine | URI; SBB000838; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]pyrimidine-2,4-dione; SMR000058222; MLS000069625; AIDS185903; 1-beta-D-Ribofuranosyluracil; NSC 20256; 1-[(2R,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]-3H-PYRIMIDINE-2,4-DIONE; SY005419; AKOS015960347; MolPort-005-932-481; AC-10519; araU; 12693-39-9; ZINC02583633; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione; AB0012293; Uracil-1-beta-D-ribofuranoside; SCHEMBL890304; NCGC00142368-01; C00299; 1-beta-D-ribofuranosylpyrimidine-2,4(1H,3H)-dione; BG00950366; U3750_SIGMA; Uridine, labeled with tritium; AI3-52690; AIDS-185903; U3003_SIGMA; AS-12665; Uracil, 1-beta-D-ribofuranosyl-; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]pyrimidine-2,4-quinone; 21231-59-4; U6381_SIGMA; SMP1_000029; CHEBI:16704; 68184-15-6; 1-((2r,5r)-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1h-pyrimidine-2,4-dione; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione; EINECS 200-407-5 | 244.201 | ||
| TCMBANKIN037504 | β-Bisabolene | (1S)-bisabola-4,7(11),10(15)-triene; (-)-beta-bisabolene; beta-Bisabolene; Cyclohexene, 1-methyl-4-(5-methyl-1-methylene-4-hexenyl)-, (S)-; (S)-(-)-6-methyl-2-(4-methyl-3-cyclohexen-1-yl)-1,5-heptadiene; LMPR0103060013; beta-bisabolene ; β-Bisabolene; UNII-S19BRC22QA; (1S)-bisabola-4,7(11),10(15)-triene (4S)-1-methyl-4-(5-methyl-1-methylenehex-4-en-1-yl)cyclohexene; 1-Methyl-4-(5-methyl-1-methylene-4-hexenyl)-1-cyclohexene-, (4S)-; (4R)-1-methyl-4-(6-methylhepta-1,5-dien-2-yl)cyclohexene; S19BRC22QA; XZRVRYFILCSYSP-OAHLLOKOSA-N; InChI=1/C15H24/c1-12(2)6-5-7-14(4)15-10-8-13(3)9-11-15/h6,8,15H,4-5,7,9-11H2,1-3H; CHEBI:49263; C19751; 1-methyl-4-(5-methyl-1-methylenehex-4-en-1-yl)cyclohexene; (4R)-1-methyl-4-(5-methyl-1-methylene-hex-4-enyl)cyclohexene; cyclohexene, 1-methyl-4-(5-methyl-1-methylene-4-hexenyl)-; FT-0622892; (-)-.beta.-bisabolene; .beta.-Bisabolene; 495-61-4; β- bisabolene; (+,-)-.beta.-Bisabolene; (-)-b-bisabolene,b-bisabolene,6-methyl-2-(4-methyl-3-cyclohexen-1-yl)-1,5-heptadiene; (4R)-1-methyl-4-(5-methyl-1-methylenehex-4-enyl)cyclohexene; l-beta-Bisabolene; l-.beta.-Bisabolene; (S)-1-Methyl-4-(5-methyl-1-methylene-4-hexenyl)cyclohexene; beta-bisabolene; (S)-beta-bisabolene; (4S)-1-methyl-4-(5-methyl-1-methylenehex-4-en-1-yl)cyclohexene; CHEMBL1077088; C16775; ZINC1846611; 1-Methyl-4-(5-methyl-1-methylene-4-hexenyl)-(S)-cyclohexene; (s)-1-methyl-4-(5-methyl-1-methylene-4-hexenyl)-cyclohexene; 1,5-Heptadiene, 6-methyl-2-(4-methyl-3-cyclohexen-1-yl)-, (S)-(-)- | 204.35 g/mol | ||
| TCMBANKIN037608 | Protopanaxatriol | AKOS015895694; protopanaxatriol ; ST51051247 | 476.7 g/mol | ||
| TCMBANKIN037671 | bicyclogermacrene | Bicyclogermacrene; CHEMBL509566; CHEBI:63709; bicyclogermacrene | C15H24 | 204.351 | C1(C([H])([H])[H])(C([H])([H])[H])[C@]([H])(\C([H])=C(/C([H])([H])[H])\C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])C2([H])[H])[C@@]12[H] |
| TCMBANKIN037817 | γ-selinene | gamma-selinene; γ- Selinene; Eudesma-4(14),7(11)-diene - Substance | C15H24 | 204.35 | CC(=C1CCC2(CCCC(=C)C2C1)C)C |
| TCMBANKIN038222 | chloropanaxydiol | CTK4A8857; AC1L2XYD; 114687-51-3; 4,6-Octadiyne-2,3-diol,1-chloro-8-(3-heptyloxiranyl)- (9CI); ACMC-20mkqa; 1-Chloro-8-(3-heptyloxiranyl)-4,6-Octadiyne-2,3-diol; Chloropanaxydiol; 1-chloro-8-(3-heptyloxiran-2-yl)octa-4,6-diyne-2,3-diol; 4,6-Octadiyne-2,3-diol, 1-chloro-8-(3-heptyloxiranyl)-; 1-Chloro-9,10-epoxy-4,6-heptadecadiyne-2,3-diol; CEHD | C17H25ClO3 | 312.8 g/mol | CCCCCCCC1C(O1)CC#CC#CC(C(CCl)O)O |
| TCMBANKIN038532 | δ-Cadinene | δ- cadinene | 204.39 | ||
| TCMBANKIN038671 | γ-Cadinene | γ- Cadinene; γ-Cadinene; γ- cadinene | 204.35 | ||
| TCMBANKIN038757 | 1-methoxy-(9r,10s)-epoxyheptadecan-4,6-diyn-3-one | CCCCCCCC1C(O1)CC#CC#CC(=O)CCOC | |||
| TCMBANKIN038817 | Frutinone A | FT-0668883; frutinone a; I14-21786; 6H,7H-chromeno[4,3-b]chromene-6,7-dione; ACM38210274; 6H,7H-[1]Benzopyrano[4,3-b][1]benzopyran-6,7-dione; CHEBI:5179; SCHEMBL11869493; 38210-27-4; AC1L9C0Q; AKOS015906673; chromeno[3,2-c]chromene-6,7-quinone; chromeno[4,3-b]chromene-6,7-dione; ZINC00897930; chromeno[3,2-c]chromene-6,7-dione; ZINC897930; C09008; DTXSID90331693 | C16H8O4 | 264.232 | c1([H])c([H])c(C(=O)C(C(=O)Oc(c([H])c([H])c([H])c2[H])c23)=C3O4)c4c([H])c1[H] |
| TCMBANKIN039000 | ginsenoside iii | C48H80O19 | 961.1 g/mol | CC(=C)C(=O)CCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)CO)O)O)O | |
| TCMBANKIN039287 | Panaxydol | 72800-72-7; (3R)-8-[(2R,3S)-3-heptyloxiran-2-yl]oct-1-en-4,6-diyn-3-ol; panaxydol ; (3R)-8-[(2R,3S)-3-heptyl-2-oxiranyl]oct-1-en-4,6-diyn-3-ol; 1-Octene-4,6-diyn-3-ol, 8-(3-heptyloxiranyl)-; 2alpha-Heptyl-3beta-(6-hydroxy-7-octene-2,4-diynyl)oxirane | 260.371 | ||
| TCMBANKIN039331 | Syrionylglycerol-beta-syringaresinol | syrionylglycerol-beta-syringaresinol | C45H60O23 | 969.05 | [C@]1([H])(O[H])[C@@]([H])(O[H])[C@]([H])(C([H])([H])O[H])O[C@]([H])(Oc2c(OC([H])([H])[H])c([H])c([C@]3([H])[C@@]([H])(C([H])([H])O[C@@]4([H])c5c([H])c(OC([H])([H])[H])c(O[C@]([H])([C@@]([H])(O[H])c6c ([H])c(OC([H])([H])[H])c(O[C@@]7([H])O[C@@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]7([H])O[H])c(OC([H])([H])[H])c6[H])C([H])([H])O[H])c(OC([H])([H])[H])c5[H])[C@]4([H])C([H])([H])O3)c ([H])c2OC([H])([H])[H])[C@@]1([H])O[H] |
| TCMBANKIN039644 | Smitilbin | smitilbin | C21H22O11 | 450.39 | CC1C(C(C(C(O1)OC2C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=CC(=C4)O)O)O)O)O |
| TCMBANKIN039673 | α-Neoclovene | ||||
| TCMBANKIN039760 | ginsenol | (1R,4S,7R,8S)-1,5,5,8-TETRAMETHYLTRICYCLO[5.4.0.0?,?]UNDECAN-7-OL; acetylginsenol; AC1MIZND; 1,4-Ethano-3aH-inden-3a-ol, octahydro-2,2,4,7a-tetramethyl-, (1S-(1alpha,3abeta,4alpha,7abeta))-; CHEMBL470270; 117591-80-7; Ginsenol | C15H26O | 222.37 g/mol | CC1(CC2(C3(CCCC2(C1CC3)C)C)O)C |
| TCMBANKIN040211 | Ginsenoside Rg1 | ginsenosiderg1; ginsenoside r g1; sanchinoside C1; (20S)-3beta,12beta-Dihydroxy-4,4,8beta,14alpha-tetramethyl-6alpha,20-bis(beta-D-glucopyranosyloxy)-18-norcholestane-24-ene | 801.01 | ||
| TCMBANKIN040412 | aposcopolamine | 535-26-2; Prestwick_216; Aposcopolamine | C17H19NO3 | 285.34 g/mol | CN1C2CC(CC1C3C2O3)OC(=O)C(=C)C4=CC=CC=C4 |
| TCMBANKIN040419 | panaxytriol | (3R,9S,10S)-Panaxytriol; SCHEMBL87655; heptadeca-1-ene-4,6-diyne-3,9,10-triol; Panaxytriol | C17H26O3 | 278.39 | CCCCCCCC(C(CC#CC#CC(C=C)O)O)O |
| TCMBANKIN040444 | ginsenoside rc | 2-[[2-[[17-[2-[[6-[[3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]oxymethyl]-3,4,5-trihydroxy-2-oxanyl]oxy]-6-methylhept-5-en-2-yl]-12-hydroxy-4,4,10,14-tetramethyl-1,2,3,5,6,7,8,9,11,12,13,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4,5-dihydr; ginsenosiderc; I06-0733; 2-(hydroxymethyl)-6-[6-(hydroxymethyl)-2-[[17-[2-[6-[[5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-methyl-hept-5-en-2-yl]-4,4,10,14-tetramethyl-12-oxidanyl-1,2,3,5,6,7,8,9,11,12,13,15,16,17-tetradecahydrocy; A802167 | C53H90O22 | 1079.27 | CC(=CCCC(C)(C1CCC2(C1C(CC3C2CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(O8)CO)O)O)O)O)O)C |
| TCMBANKIN040819 | 2,4,6-Trihydroxyacetophenone-2,4-di-O-β-D-glucopyranoside | ||||
| TCMBANKIN040843 | Kaempferol-3-arabofuranoside | kaempferol-3-arabofuranoside | C20H18O10 | 418.351 | c1([H])c(O[H])c(C(=O)C(O[C@]2([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O2)=C(c3c([H])c([H])c(O[H])c([H])c3[H])O4)c4c([H])c1O[H] |
| TCMBANKIN040933 | 7-(beta-Xylosyl)cephalomannine | 7-(β-xylosyl)cephalomannine; 7-(beta-xylosyl)cephalomannine | C51H63NO17 | 962.15 | [C@@]1([H])(OC(=O)C([H])([H])[H])C(=C(C([H])([H])[H])[C@]([H])(OC(=C([H])[H])[C@]([H])(O[H])[C@@]([H])(N([H])C(=O)\C(=C([H])\C([H])([H])[H])\C([H])([H])[H])c2c([H])c([H])c([H])c([H])c2[H])C3([H])[H])C (C([H])([H])[H])(C([H])([H])[H])[C@]3(O[H])[C@]([H])(OC(c4c([H])c([H])c([H])c([H])c4[H])=O)[C@]([H])([C@@]5(OC(=O)C([H])([H])[H])[C@]([H])(OC5([H])[H])C([H])([H])[C@@]6(O[C@]7([H])OC([H])([H])[C@]([H] )(O[H])[C@]([H])(O[H])[C@@]7([H])O[H])[H])[C@]6(C([H])([H])[H])C1=O |
| TCMBANKIN041154 | gypenoside LXIX | Ginsenoside-Rb3; gypenoside lxix | C53H90O24 | 1111 | [C@]1([H])(O[H])C([H])([H])O[C@@]([H])(OC([H])([H])[C@@]([H])(O[C@@]([H])(O[C@@]([C@@]2([H])C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@](C([H])([H])[H])(C([H])([H])C([H])([H])[C@]([H])(C(C([H])([H ])[H])(C([H])([H])[H])[C@@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[C@]([H])(O[C@]([H])(C([H])([H])O[H])[C@@]4([H])O[H])[C@]([H])(O[H])[C@@]4([H])O[H])[C@@]([H])(C([H])([H])O[H])O3 )[C@]([H])(O[H])C5([H])[H])[C@]56C([H])([H])[H])[C@@]6([H])C([H])([H])[C@@]7([H])O[H])[C@@]27[H])(C([H])([H])[H])C([H])([H])\C([H])=C([H])\C(O[H])(C([H])([H])[H])C([H])([H])[H])[C@]([H])(O[H])[C@@]8([ H])O[H])[C@@]8([H])O[H])[C@]([H])(O[H])[C@@]1([H])O[H] |
| TCMBANKIN041672 | ginsenoside Rf | (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-; C08945; (2S,3R,4S,5S,6R)-2-[[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-; ginsenoside r f; ginsenoside-rf; Ginsenoside Rf; (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-; ginsenosiderf; 52286-58-5; (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6 | C42H72O14 | 801 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])(O[H])C([H])([H])[H])C([H])( [H])C2([H])[H])[C@@]23C([H])([H])[H])[C@@]3(C([H])([H])[H])C([H])([H])[C@]4([H])O[C@@]5([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]5([H])O[C@@]6([H])O[C@@]([H])(C([H])([H])O[H] )[C@]([H])(O[H])[C@@]([H])(O[H])[C@]6([H])O[H])[C@@]4([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
| TCMBANKIN041696 | Stigmasterol-3-(6-oleoyl)glucopyranoside | ||||
| TCMBANKIN042052 | (9R,10S)-Epoxyheptadecan-4,6-diyn-3-one | 260.4 g/mol | |||
| TCMBANKIN042098 | Stigmasterol-3-(6-linoleoyl)glucopyranoside | ||||
| TCMBANKIN042209 | ginsenoside f4 | ginsenoside f 4 | C42H70O12 | 767 g/mol | CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CC4(C(CC(C5C4(CCC5C(=CCC=C(C)C)C)C)O)C6(C3C(C(CC6)O)(C)C)C)C)CO)O)O)O)O)O |
| TCMBANKIN042337 | Ditertbutyl phthalate | Di-(terc-butilperoxi)ftalato; 30448-43-2; SCHEMBL109178; DTXSID10184527; EINECS 250-204-0; benzene-1,2-dicarboxylic acid ditert-butyl ester; Diperoxyphtalate de tert-butyle; 1,2-Benzenedicarboxylicacid, 1,2-bis(1,1-dimethylethyl) ester; AC1L3T9P; ditertbutyl phthalate; AKOS030616148; CTK4G5219; AK661164; Phthalic acid ditert-butyl ester; Peroxyphthalic acid, di-tert-butyl ester (8CI); Di-(tert-butylperoxy) phthalate, >55% in solution; AC1Q5XKL; ditert-butyl benzene-1,2-dicarboxylate; ZINC5353715; Di-tert-butyl phthalate; ACM30448432; 1,2-DI-TERT-BUTYL PHTHALATE; 134115-67-6 | C16H22O4 | 278.34 | CC(C)(C)OC(=O)C1=CC=CC=C1C(=O)OC(C)(C)C |
| TCMBANKIN042679 | ginsinsene | C15H24 | 204.35 g/mol | CC1CCC2C3=C(CCC13CC2(C)C)C | |
| TCMBANKIN042839 | Darutoside | stigmasterol-beta-D-glucoside; Stigmasterol-beta-D-glucoside_qt; stigmasterol 3-O-beta-D-glucoside | C26H44O8 | 485 | C1([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@@]2([H])C(=C([H])[C@]([C@]([H])(C([H])([H])O[H])O[H])(C([H])([H])[H])C([H])([H])C2([H])[H])C([H])([H])C3([H])[H])[C@@]3([H])C(C([H])([H])[H])(C([H])([H] )[H])[C@]1([H])O[C@@]4([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[H] |
| TCMBANKIN042969 | β-panasinsene | beta-Phellandrene; beta-Panasinsene | C15H24 | 204.35 | CC1(CC23C1CCC2(CCCC3=C)C)C |
| TCMBANKIN043073 | 3-O-beta-D-Glucuronopyranosyl gypsogenin | 3-o-β-d-glucuronopyranosyl gypsogenin; 3-o-beta-d-glucuronopyranosyl gypsogenin | C36H54O10 | 646.9 | C1([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C(=O)O[H])C([H])([H])C3([H])[H])[C@@]34C ([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])[C@@](C(=O)[H])(C([H])([H])[H])[C@]1([H])O[C@@]6([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C(=O)O[H])O6 |
| TCMBANKIN043469 | γ-Elemene | O-Menth-8-ene, 4-isopropylidene-1-vinyl-; 1-ethenyl-1-methyl-2-(1-methylethenyl)-4-(1-methylethylidene)-cyclohexane; γ- elemene; γ--elemene; γ-Elernene | 204.35 | ||
| TCMBANKIN043737 | Neointermedeol | 222.37 g/mol | |||
| TCMBANKIN044178 | Dihydroresveratrol | CTK5A8302; dihydroresveratrol; W2088; 3,4'',5-trihydroxybibenzyl; 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethyl)-; DB08466; 5-[2-(4-Hydroxy-phenyl)-ethyl]-benzene-1,3-diol; D00TWK; 3ftu; FT-0756540; 5-[2-(4-hydroxyphenyl)ethyl]resorcinol; a, b-Dihydroresveratrol; C10255; 5-(4-hydroxyphenethyl)benzene-1,3-diol; 3,5,4'-trihydroxybibenzyl; alpha,beta-dihydro-3,40,5-trihydroxystilbene; AK586206; 3,4',5-Trihydroxybibenzyl; CHEBI:4582; 58436-28-5; Dihydroresveratol; 5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol; MolPort-035-706-156; 5-[2-(4-hydroxyphenyl)ethyl]-1,3-Benzenediol; 151363-17-6; AC1Q79W7; BDBM50085531; RE2; LMPK13090035; Dihydro-Resveratrol; AC1L4HRG; ZINC899123; CHEMBL111234; NSC723534; AKOS030555676; NSC-723534; 4CN-1275; SCHEMBL716856 | C14H14O3 | 230.26 | C1=CC(=CC=C1CCC2=CC(=CC(=C2)O)O)O |
| TCMBANKIN044510 | Ginsenoside Rg2 | ginsenoside r g2; chikusetsusaponinⅠ; ginsenoside-Rg2; ginsenosiderg2; ginsenoside rg2; ginsenoside- Rg2; ginsenoside-rg2 | 785 | ||
| TCMBANKIN044727 | salicylic acid | 3320-EP2298732A1; D00097; CCRIS 6714; 3320-EP2287148A2; 3320-EP2298735A1; o-Hydroxybenzoate anion; Trans-Ver-Sal; Verrugon; CHEBI:30762; STK258681; 2y7w; salicylate; BBL000698; 3320-EP2305260A1; 3320-EP2311796A1; K 537; Keralyt; AC1L1JPL; Salicylate anion; 3320-EP2301534A1; Orthohydroxybenzoic acid; 3320-EP2292595A1; o-hydroxybenzoic acid; Salicylate ion; 3320-EP2298777A2; ACS No 10; Ionil; 3320-EP2289871A1; Salicylic acid [USAN:JAN]; 3320-EP2298748A2; SMR000059163; AC1Q5BFS; o-Carboxyphenol; NCGC00178624-02; 3320-EP2269991A2; 25496-36-0; 3320-EP2292614A1; 3320-EP2311451A1; Salicylic acid; YGSDEFSMJLZEOE-UHFFFAOYSA-M; 3320-EP2284179A2; Benzoic acid, 2-hydroxy-; 3320-EP2287150A2; MLS000069653; 3320-EP2301912A2; CHEBI:16914; Ionil-Plus; Salicylic acid & Sulfur Soap; 3320-EP2305637A2; 3320-EP2298743A1; 3320-EP2284151A2; 54-21-7 (SODIUM SALT); AB00053542_03; Salicylic acid collodion; Kyselina 2-hydroxybenzoova [Czech]; Salicylic acid (6CI,8CI); AIDS-006789; 3320-EP2295416A2; KBio2_003996; 2-hydroxy-benzoate; Dr. Scholl's Corn Removers; 3320-EP2284152A2; Advanced Pain Relief Corn Removers; 3320-EP2284156A2; NCGC00159447-02; 3320-EP2316835A1; 3320-EP2295413A1; 3320-EP2308863A1; 3320-EP2292593A2; 3320-EP2305671A1; AIDS006789; Duofil Wart Remover; 2-Hydroxybenzoic acid; 3gf2; InChI=1/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10; 3320-EP2269985A2; C00805; 3twp; 3320-EP2311798A1; 3320-EP2275420A1; hydroxybenzoate; WLN: QVR BQ; Salonil; S7401_SIGMA; NSC 180; Salicylic acid (JP15/USP); 3320-EP2301927A1; 3198-EP2289876A1; 3320-EP2316470A2; NCGC00178624-03; Saligel; 2-HYDROXYPHENYLFORMATE; salicylicacid; CPD-110; 3320-EP2284150A2; Spectrum_000948; EPA Pesticide Chemical Code 076602; 3320-EP2284164A2; 3320-EP2295550A2; SMP2_000145; Acidum salicylicum; CAS_54-21-7; Dr. Scholl's Callus Removers; Stri-Dex; ZB000360; SAL; o-Hydroxybenzoate; 3320-EP2280008A2; Clear away Wart Remover; 3320-EP2295432A1; S8519_SIGMA; CTK5I4917; CJ-00055; Salicylic acid, tech.; Salicylic acid soap; 3320-EP2269978A2; 2-Hydroxybenzoate (Na+); Benzoic acid, 2-hydroxy-, ion(1-); SGCUT00012; Duoplant; Freezone; 3320-EP2284155A2; Occlusal; 3320-EP2284178A2; 3320-EP2301914A1; 3320-EP2311825A1; MFCD00984876; Psoriacid-S-Stift; 3320-EP2301913A1; Rutranex; IDI1_000301; 3320-EP2314578A1; 2-Hydroxybenzenecarboxylic acid; 3320-EP2298765A1; 3320-EP2308832A1; MolPort-003-710-545; 8052-31-1; o-Hydrobenzoate; Retarder W; Salicylic acid-ring-UL-14C; 2y7k; Duofilm; o-Hydrobenzoic Acid; NSC_5900; EINECS 200-712-3; NCGC00159447-04; BDBM85513; 3320-EP2295419A2; 3320-EP2314295A1; STK372903; 63-36-5; 3320-EP2311835A1; DivK1c_000301; 2-Hydroxybenzoic acid ion(1-); 3320-EP2316450A1; 3320-EP2277875A2; Dr. Scholl's Wart Remover Kit; 105910_ALDRICH; HSDB 672; 69-72-7; 3320-EP2311842A2; 2y7p; 3320-EP2284153A2; AI3-02407; 3320-EP2272847A1; 7681-06-3; Phenol-2-carboxylic acid; AKOS005447222; 3198-EP2298777A2; Ionil Plus; KBioSS_001428; 3320-EP2301916A2; T7104; 3320-EP2284170A1; 3320-EP2298764A1; Caswell No. 731; 2-Oxylatobenzoate; 84210_FLUKA; KBio1_000301; 3320-EP2311799A1; BENZOIC ACID,2-HYDROXY SALICYLIC ACID; to_000004; Compound w; 3320-EP2275102A1; 3320-EP2311797A1; 2-Hydroxybenzoate; Kyselina salicylova [Czech]; S5922_SIGMA; 3320-EP2287140A2; 2-Hydroxybenzoic acid anion; 3320-EP2305688A1; 3320-EP2305243A1; UPCMLD-DP126:001; 3320-EP2295412A1; 27301_SIAL; Salicylic acid, ion(1-); 3320-EP2292590A2; 3320-EP2277876A1; W398500_ALDRICH; Oprea1_040343; KBio2_006564; Salicylic acid (TN); Sebucare; 2-Carboxyphenol; Benzoic acid, 2-hydroxy- (9CI); Acido salicilico [Italian]; KBio2_001428; Acido o-idrossibenzoico [Italian]; Advanced Pain Relief Callus Removers; LS-144344; NINDS_000301; 2-hydroxybenzoic acid; 247588_SIAL; 2-CARBOXYBENZENOLATE; 3198-EP2314295A1; NSC180; Domerine; Sebulex; BRN 0774890; CMC_13852 | C7H6O3 | 138.12 | C1=CC=C(C(=C1)C(=O)O)[O-] |
| TCMBANKIN044888 | β-Sitosterol-3-(6-linoleoyl)glucopyranoside | ||||
| TCMBANKIN045202 | α-Panasinsene | α-panasinsene | 204.39 | ||
| TCMBANKIN045207 | cis-Widdrol alpha-epoxide | cis-widdrol α-epoxide; cis-widdrol alpha-epoxide | C15H26O2 | 238.366 | C1([H])([H])C([H])([H])[C@]2(C([H])([H])[H])[C@]3([C@]([H])(O3)C([H])([H])[C@@](C([H])([H])[H])(O[H])C([H])([H])C2([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C1([H])[H] |
| TCMBANKIN045259 | ginsenoside ia | ginsenoside i a | C42H72O14 | ||
| TCMBANKIN045695 | 7alpha-L-Rhamnosyl-6-methoxylutcolin | 7alpha-l-rhamnosyl-6-methoxylutcolin | C22H22O11 | 462.403 | c1(O[C@@]([H])(O[C@@]2([H])C([H])([H])[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])c([H])c(OC(c3c([H])c([H])c(O[H])c(O[H])c3[H])=C([H])C4=O)c4c(O[H])c1OC([H])([H])[H] |
| TCMBANKIN045789 | Chikusetsusaponin III | Chikusetsusaponin III; chikusetsusaponin iii; 29845-71-4; C17539; CHEBI:81170 | 917 | ||
| TCMBANKIN046681 | β-Neoclovene | ||||
| TCMBANKIN047089 | raffinose | Melitriose, Raffinose; alpha-D-Glucopyranoside, beta-D-fructofuranosyl O-alpha-D-galactopyranosyl (1 to 6)-; 6G-alpha-D-galactosylsucrose; alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranosyl beta-D-fructofuranoside; Gossypose; alpha-D-glucopyranoside, beta-D-fructofuranosyl O-alpha-D-galactopyranosyl-(1->6)-; 17629-30-0; alpha-D-Galp-(1->6)-alpha-D-Glcp-(1<->2)-beta-D-Fruf; alpha-D-Glucopyranoside, beta-D-fructofuranosyl O-alpha-D-galactopyranosyl-(1>6)- (9CI); beta-D-Fructofuranosyl-O-alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside; Raffinose; CHEBI:16634; 512-69-6; AIDS-014662; (2R,3R,4S,5S,6R)-2-[[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)-2-tetrahydrofuranyl]oxy]-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxymethyl]tetrahydropyran-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-dimethylol-tetrahydrofuran-2-yl]oxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-3,4,5-triol; SCHEMBL16435154; O-alpha-D-Galactopyranosyl(1,6)-O-alpha-D-glucopyranosyl-(1,2)-beta-D-fructofuranoside; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl]oxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxane-3,4,5-triol; C00492; beta-D-fructofuranosyl alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside; AIDS014662 | C18H32O16 | 504 | O([H])C([H])([H])[C@]1([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(OC([H])([H])[C@]2([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(O[C@@]3(O[C@]([H])(C([H])([H])O[H])[ C@@]([H])(O[H])[C@]3([H])O[H])C([H])([H])O[H])O2)O1 |
| TCMBANKIN047229 | Ginsenoside Ib | ||||
| TCMBANKIN047366 | Ginsenoside La | Ginsenoside-La; ginsenoside la | 783 | ||
| TCMBANKIN047423 | Panaginsene | 204.35 g/mol | |||
| TCMBANKIN047773 | ginsenoside-Rc | BRN 1677618; AC1L2NV3; 2-[(2-{[1-(2-{[6-({[3,4-DIHYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]OXY}METHYL)-3,4,5-TRIHYDROXYOXAN-2-YL]OXY}-6-METHYLHEPT-5-EN-2-YL)-11-HYDROXY-3A,3B,6,6,9A-PENTAMETHYL-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-7-YL]OXY}-4,5-DIHYDROXY-6-(HYDROXYMETHYL)OXAN-3-YL)OXY]-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL; ginsenoside Rc; Ginsenoside-Rc from Panax ginseng (Korean ginseng) root; AKOS026750610; AC1Q70KB; EINECS 234-253-5; ginsenoside-rc; NSC-310104; CHEBI:91809; Panaxoside RC; Ginsenoside-Rc from Panax ginseng (Korean ginseng) root, triterpenoid saponin, >=98% (HPLC); 11021-14-0; 2-[(2-{[14-(2-{[6-({[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-6-methylhept-5-en-2-yl)-16-hydroxy-2,6,6,10,11-pentamethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadecan-5-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol; 20-((6-O-alpha-L-Arabinofuranosyl-beta-D-glucopyranosyl)oxy)-12beta-hydroxydammar-24-en-3beta-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; ginsenoside- Rc; LS-71253; FT-0626702; 2-[2-[[17-[2-[6-[[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-6-methylhept-5-en-2-yl]-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; NSC310104; SMP2_000126; BRD-A65550283-001-01-9; 12-hydroxy-20-[(6-o-pentofuranosylhexopyranosyl)oxy]dammar-24-en-3-yl 2-o-hexopyranosylhexopyranoside | C52H88O22 | 1065 | [C@]1([H])([C@](O[C@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[C@@]3([H])O[C@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@@]3([H])O[H])O2)(C([H])([H])[H])C([H])([H])C([H] )([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])[C@@]([H])([C@@]([H])(C([H])([H])[C@]4([H])[C@@]5(C([H])([H])[H])C([H])([H])C([H])([H])[C@]6([H])[C@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]([H])(O [C@@]7([H])O[C@@]([H])(C([H])([H])O[H])[C@@]([H])(O[C@]8([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]8([H])O[H])[C@@]([H])(O[H])[C@]7([H])O[H])C6(C([H])([H])[H])C([H])([H])[H])O [H])[C@@]5([H])C([H])([H])C1([H])[H] |
| TCMBANKIN048099 | Aposiopolamine | 3-OXA-9-AZATRICYCLO[3.3.1.0(2),?]NONAN-7-YL 2-PHENYLPROP-2-ENOATE; Aponorhyoscine; aposiopolamine; 25650-56-0 | C16H17NO3 | 271.311 | c1([H])c([H])c([H])c(C(=C([H])[H])C(=O)OC2([H])C([H])([H])[C@]([H])(N([H])[C@]3([H])C2([H])[H])[C@]([H])(O4)[C@@]34[H])c([H])c1[H] |
| TCMBANKIN048102 | Stigmast-3-O-beta-D-glucopyanosyl-6-hexadecanoate | stigmast-3-o-β-d-glucopyanosyl-6-hexa-decanoate | C64H114O7 | C1([H])([H])C([H])([H])[C@]2(C([H])([H])[H])C(=C([H])C([H])([H])[C@]3([H])[C@]2([H])C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(\C([H])=C([H])\[C@]([H])(C([H])([H])C([H])([H])[H])C ([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]34[H])C([H])([H])[C@]1([H])O[C@@]5([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])OC(=O)C([H])([H ])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H]) C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])O5 | |
| TCMBANKIN048381 | 2-heptanol | 189056-EP2380568A1 | C7H16O | 116.2 g/mol | CCCCCC(C)O |
| TCMBANKIN048506 | β-Maaliene | [1aR-(1a.alpha.,3a.alpha.,7b.alpha.)]-1a,2,3,3a,4,5,6,7b- octahydro-1,1,3a,7-tetramethyl-1H-Cyclopropa[a]-naphthalene[1aR.(1a.alpha.,3a.alpha.,7ba)]; beta-maaliene; BETA-MAALIENE | 204.35 | ||
| TCMBANKIN048691 | alpha-Guttiferin | alpha-guttiferin | C27H32O6 | 452.59 | C1(C([H])([H])[H])=C(C([H])([H])[H])c2c(c(C(=O)C(\C(=C(/C([H])([H])C([H])([H])[H])\O[H])\[C@@]([H])(C([H])([H])[H])C([H])([H])C3([H])[H])=C3[H])c(O[H])c(C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H ])[H])c2O[H])OC1=O |
| TCMBANKIN048795 | trifolirhizin | C10538; trifolirhizin; ACon1_002295; (-)-Maackiain 3-O-glucoside; 6807-83-6 | C22H22O11 | 462.403 | c12c(OC([H])([H])O1)c([H])c3c(O[C@]([H])(c(c([H])c(OO[C@@]([H])(O[C@](C([H])([H])O[H])([H])[C@]4(O[H])[H])[C@@](O[H])([H])[C@@]4([H])O[H])c([H])c5[H])c5OC6([H])[H])[C@@]36[H])c2[H] |
| TCMBANKIN048807 | Ginsenoside II | 963.2 g/mol | |||
| TCMBANKIN049102 | Panaxene | 204.35 g/mol | |||
| TCMBANKIN049443 | astilbin | 4H-1-Benzopyran-4-one, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-, (2R,3R)-; (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-chroman-4-one; Isoastilbin; (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-3,4-dihydro-2H-chromen-3-yl 6-deoxy-alpha-L-mannopyranoside; (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-tetrahydropyranyl]oxy]-4-chromanone; astilbin ; (2R-trans)-3-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-4H-1-benzopyran-4-one; 4H-1-Benzopyran-4-one, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-, (2R-trans)-; MEGxp0_000363; CHEBI:38200; ACon1_000616; Neoisoastilbin; (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychroman-4-one; (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-chroman-4-one | C21H22O11 | 450.39 | CC1C(C(C(C(O1)OC2C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C4)O)O)O)O)O |
| TCMBANKIN049575 | ginsenoside i | C48H82O20 | 979.2 g/mol | CC(=C)C(CCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)CO)O)O)O)OO | |
| TCMBANKIN050111 | gomisin A | AKOS032948318; ZWRRJEICIPUPHZ-DAOPMYJZSA-N; ZINC11616528; Gomisin A; CHEMBL1159658; (6R)-1,2,3,13-Tetramethoxy-6,7beta-dimethyl-5,6,7,8-tetrahydrobenzo[3,4]cycloocta[1,2-f][1,3]benzodioxol-6beta-ol | C23H28O7 | 416.464 | C1([H])([H])Oc(c([H])c(C([H])([H])[C@@](C([H])([H])[H])([H])[C@@](C([H])([H])[H])(O[H])C([H])([H])c(c([H])c(OC([H])([H])[H])c(OC([H])([H])[H])c2OC([H])([H])[H])c23)c3c4OC([H])([H])[H])c4O1 |
| TCMBANKIN050218 | panaxacol | DTXSID70147794; 106828-96-0; (9R,10R)-9,10-dihydroxyheptadeca-4,6-diyn-3-one; AC1L2VLC; Panaxacol; 4,6-Heptadecadiyn-3-one, 9,10-dihydroxy-, (R-(R*,R*))- | C17H26O3 | 278.4 g/mol | CCCCCCCC(C(CC#CC#CC(=O)CC)O)O |
| TCMBANKIN050305 | 1-hexadecyne | hexadec-1-yne; EINECS 211-106-3; 629-74-3; SBB008791 | C16H30 | 222.409 | C([H])#CC([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] |
| TCMBANKIN057142 | Ruvoside | UN2330; 1120-21-4; CAS-1120-21-4; LTBB002321; LS-158394; UN 2330; UNII-JV0QT00NUE; DSSTox_CID_1689; AI3-21126; U203; ACMC-209t6p; MolPort-001-783-218; Jsp000912; CCRIS 3796; Undecane [UN2330] [Flammable liquid]; EC 214-300-6; UND; undecyl group; 4-01-00-00487 (Beilstein Handbook Reference); KSC176C3J; Undecane; ANW-42095; 175476-97-8; DSSTox_RID_76285; AC1L23G2; n-Undecane, 99% 50g; Undekan; Undecane, 99%; QSPL 058; 17398EC4-D16F-42F6-8A27-60F8EC075469; BRN 1697099; Undecane, >=99%; TR-002350; InChI=1/C11H24/c1-3-5-7-9-11-10-8-6-4-2/h3-11H2,1-2H; UNDECAN-2-YL; MCULE-7319807036; NSC 66159; EINECS 214-300-6; J-002689; RSJKGSCJYJTIGS-UHFFFAOYSA-N; NCGC00254001-01; DTXSID9021689; n-C11H24; U0002; S0283; undecan; DSSTox_GSID_21689; SC-79237; CHEMBL132474; Undecane, analytical standard; JV0QT00NUE; MFCD00008959; Hendekan; HSDB 5791; CH3-[CH2]9-CH3; NCGC00247896-01; C-28174; CC-33184; N-UNDECANE; AKOS005145675; FT-0633353; AN-20593; 61193-21-3; 55101-35-4; KS-00000WJI; NSC66159; NSC-66159; I14-60624; ZINC1693211; Hendecane; Decane, methyl-; n-Hendecane; LMFA11000591; CHEBI:46342; TRA0090240; Undecane [UN2330] [Flammable liquid]; DB-041031; CTK0H6134; RTR-002350; Tox21_300076;LMFA11000001; Tridekan; InChI=1/C13H28/c1-3-5-7-9-11-13-12-10-8-6-4-2/h3-13H2,1-2H; CH3-[CH2]11-CH3; 629-50-5; 91490_FLUKA; 442713_SUPELCO; HSDB 5727; n-Tridecane; EINECS 211-093-4; NSC66205; T57401_ALDRICH; Tridecane; CHEBI:35998; NSC 66205; TRIDECANE, N-; C13834;Tridekan; UNII-114P5I43UJ component IIYFAKIEWZDVMP-UHFFFAOYSA-N; MCULE-7749861366; U393; DB-054344; Tridecane_GurudeebanSatyavani; ACMC-209t6w; C13H28; C13834; N-TRIDECANE; 757DB156-6441-49B0-A824-1532074AC0F6; NCGC00257175-01; IIYFAKIEWZDVMP-UHFFFAOYSA-N; Tridecane, >=99%; TL8004327; MolPort-003-933-018; LS-157141; AN-22061; STL301147; CAS-629-50-5; tridecan; LMFA11000001; SC-74775; AC1L1ZHL; LTBB002872; DSSTox_CID_7266; C-28190; InChI=1/C13H28/c1-3-5-7-9-11-13-12-10-8-6-4-2/h3-13H2,1-2H; Tridecane, 99.0%; TRA0008560; I14-59696; KSC353S8D; UNII-FW7807707B component IIYFAKIEWZDVMP-UHFFFAOYSA-N; S0285; Dodecane, methyl-; AKOS016011009; FT-0632663; Tridecane, analytical standard; Alkanes, C12-14; MFCD00008979; UNII-A3LZF0L939; DSSTox_GSID_27266; RT-000404; CHEMBL135694; tridecyl group; KS-00000XDT; ST24031950; HSDB 5727; EINECS 211-093-4; AC1Q28TY; DSSTox_RID_78377; FT-0082500; DTXSID6027266; CC-33178; A3LZF0L939; Tox21_303043; NSC-66205; Tridecane; CH3-[CH2]11-CH3; CTK2F3981; TRD; EC 211-093-4; NSC66205; AK115985; ANW-42102; 629-50-5; CHEBI:35998; NSC 66205; TRIDECANE, N-; ZINC1693738;n-tridecane;TRD | C30H46O9 | [C@]1([H])(OC([H])([H])[H])[C@@]([H])(O[H])[C@]([H])(C([H])([H])[H])O[C@@]([H])(O[C@@]2([H])C([H])([H])[C@]3([H])[C@@](C([H])([H])O[H])([C@@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@]([H])( C4=C([H])C(=O)OC4([H])[H])C([H])([H])C5([H])[H])[C@]56O[H])[C@@]6([H])C([H])([H])C3([H])[H])C([H])([H])C2([H])[H])[C@@]1([H])O[H] | |
| TCMBANKIN057922 | malonicacid | malonic acid; MLI; AI3-15375; C00383; DICARBOXYLIC ACID C3; InChI=1/C3H4O4/c4-2(5)1-3(6)7/h1H2,(H,4,5)(H,6,7; Dicarboxylate; PROPANEDIOIC ACID MALONIC ACID; AIDS-017691; malonic acid; 1,3-Propanedioic acid; Malonic acid (8CI); propanedioic acid; Carboxyacetic acid; Methanedicarboxylic acid; C02028; METAHNEDICARBOXYLIC ACID; Dicarboxymethane; Malonate standard for IC; C04025; alpha,omega-Dicarboxylic acid; 141-82-2; AIDS017691; MLA; NSC8124; PROPANEDIOLIC ACID; Usaf ek-695; 4-02-00-01874 (Beilstein Handbook Reference); HOOC-CH2-COOH; ST5213926; 49323_FLUKA; Propanedioic acid (9CI); M1296_SIAL; 211863-95-5; nchembio.2007.22-comp12; WLN: QV1VQ; CHEBI:30794; Kyselina malonova [Czech]; Dicarboxylic acid; NSC 8124; BRN 1751370; EINECS 205-503-0; LMFA01170041; 46938U_SUPELCO; H2malo | C3H4O4 | 104.06 g/mol | C(C(=O)O)C(=O)O |
| TCMBANKIN057932 | D-erythro-Isocitric acid | 3-carboxy-2,3-dideoxy-D-erythro-pentaric acid; 30810-51-6; CHEBI:160; (1S,2S)-1-hydroxypropane-1,2,3-tricarboxylic acid; C04617; isocitric acid b; isocitric acid c | C6H8O7 | 192.12 | C(C(C(C(=O)O)O)C(=O)O)C(=O)O |
| TCMBANKIN057949 | sucrose | Amerfand; 29253-78-9; Sucrose (TN); alpha-D-Glucopyranoside, beta-D-fructofuranosyl-; saccharose; Sugar, compressible (NF); S0389_SIGMA; D06530; C00089; 1-alpha-D-Glucopyranosyl-2-beta-D-fructofuranoside; Sucrose, purified; 8027-47-2; 30027-72-6; 29764-06-5; 86101-30-6; NSC 406942; D06529; Sucrose [USAN:JAN]; 146187-04-4; ST5308554; Sugar, confectioner's; D(+)-Saccharose; S7903_SIGMA; GLC-(1-2)FRU; alpha-D-glucopyranosyl beta-D-fructofuranoside; FICOLL; 151756-02-4; Sugar spheres (NF); White soft sugar (JP15); Sucraloxum [INN-Latin]; Saccharum; alpha-D-Glc-(1-2)-beta-D-Fru; S9378_SIGMA; 76056-38-7; 47289_SUPELCO; D-Sucrose; Sugar spheres; 87430-66-8; 104242-10-6; (alpha-D-Glucosido)-beta-D-fructofuranoside; Table sugar; Sacharose; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; NCI-C56597; 47167-52-2; CCRIS 2120; alpha-D-Glucopyranoside, beta-D-fructofuranosyl, homopolymer; D06528; Microse; Cane sugar; Amerfond; 64533-66-0; White soft sugar; beta-D-Fruf-(2<->1)-alpha-D-Glcp; sugar; White sugar; SUC; 84097_FLUKA; Rock candy; beta-D-Fructofuranosyl-alpha-D-glucopyranoside; Fructofuranoside, alpha-D-glucopyranosyl, beta-D; 80165-03-3; 47257-91-0; CHEBI:17992; 47185-09-1; S5390_SIGMA; alpha-D-Glucopyranoside, beta-D-fructofuranosyl; S1888_SIGMA; 220376-22-7; D06533; 8030-20-4; S3929_SIGMA; S1174_SIGMA; 65545-99-5; Glucopyranoside, beta-D-fructofuranosyl, alpha-D; S2395_SIGMA; 78654-77-0; D06531; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; SUCROSE; S5016_SIAL; 51909-69-4; 85456-51-5; D()-Saccharose; ZINC04217475; 84100_FLUKA; D00025; Confectioner's sugar; EINECS 200-334-9; Sugar, confectioner's (NF); 57-50-1; 100405-08-1; 92004-84-7; Beet sugar; S5391_SIGMA; Sucrose, dust; alpha-D-Glc-(1->2)-beta-D-Fru; beta-D-Fructofuranosyl alpha-D-glucopyranoside; 131932-12-2; HSDB 500; Sugar, compressible; AI3-09085; alpha-D-Glucopyranosylbeta-D-fructofuranoside; Rohrzucker; 16104_RIEDEL; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-dimethylol-tetrahydrofuran-2-yl]oxy-6-methylol-tetrahydropyran-3,4,5-triol; Granulated sugar; S8501_SIGMA; Sucrose, purified (JAN); 146054-35-5; Sucrose (JP15/NF); 9012-95-7; Sucrose, pure; 75398-84-4; 50857-68-6; (2R,3R,4S,5S,6R)-2-[[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)-2-tetrahydrofuranyl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; 25702-74-3; D(+)-Sucrose | C12H22O11 | 342.3 g/mol | C(C1C(C(C(C(O1)OC2(C(C(C(O2)CO)O)O)CO)O)O)O)O |
| TCMBANKIN057963 | succinic acid | NCGC00159372-02; AIDS017693; Bernsteinsaure; succ; nchembio856-comp9; SIN; Butanedioic acid diammonium salt; InChI=1/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8; Bernsteinsaeure; ST5213944; nchembio.2007.47-comp2; 4-02-00-01908 (Beilstein Handbook Reference); 623158-99-6; LMFA01170043; BRN 1754069; butanedioic acid; Succinic acid (8CI); acide butanedioique; Dihydrofumaric acid; Katasuccin; 110-15-6; WLN: QV2VQ; FMR; AI3-06297; EINECS 203-740-4; Kyselina jantarova [Czech]; Amber acid; 398055_SIAL; 1,4-Butanedioic acid; S3674_SIAL; succinicacid; Ethylene dicarboxylic acid; 1,4-BUTANEDIOIC ACID (SUCCINIC ACID); S7501_SIAL; NSC25949; Bernsteinsaure [German]; acide succinique; NSC 106449; HOOC-CH2-CH2-COOH; Butandisaeure; 1,2-Ethanedicarboxylic acid; Acidum succinicum; Asuccin; C00042; Wormwood acid; ethylenesuccinic acid; Wormwood; 14078_FLUKA; Butanedionic acid; NSC106449; W502707_ALDRICH; W502715_ALDRICH; NCGC00159372-03; AIDS-017693; spirit of amber; A 12084; CHEBI:15741; Butanedioic acid (9CI); S9512_SIGMA; 14079_FLUKA; HSDB 791; Amber acid; amber acid | C4H6O4 | 118.09 g/mol | C(CC(=O)O)C(=O)O |
| TCMBANKIN057976 | SPD;spermidine | 124-20-9 (FREE BASE); KBioSS_000345; Lopac0_001047; SPBio_000947; 4-04-00-01300 (Beilstein Handbook Reference); BRN 1698591; 85561_FLUKA; NCI60_004294; Spermidine 0.1 M solution; Spermidine solution; 1,8-Diamino-4-azaoctane; KBio2_005481; 05292_FLUKA; IDI1_001007; 334-50-9 (TRIHYDROCHLORIDE); NCGC00015937-01; NCGC00024903-03; Spectrum3_000977; NSC528399 (TRIHYDROCHLORIDE); SDCCGMLS-0066822.P001; Lopac-S-2501; SPERMIDINE; KBio3_001833; 1,5,10-Triazadecane; 1,4-Diaminobutane, N-(3-aminopropyl)-; Spermidin; N-(2-AMINO-PROPYL)-1,4-DIAMINOBUTANE; S2626_SIGMA; AIDS005223; Spectrum4_001101; 85558_FLUKA; KBio1_001007; Spectrum2_000874; N-(3-Aminopropyl)-1,4-diaminobutane; N-(3-Aminopropyl)-1,4-butanediamine; 4-aminobutyl-(3-aminopropyl)amine; DivK1c_001007; NINDS_001007; Spectrum5_001561; Spectrum_000005; AI3-26636; N-(3-aminopropyl)butane-1,4-diamine; KBio2_000345; S4139_SIGMA; KBioGR_001542; EINECS 204-689-0; 124-20-9; AIDS-005223; Tocris-0959; PA(34); Additive Screening Solution 30/Fluka kit no 78374; KBio2_002913; 4-azaoctane-1,8-diamine; 4-Azaoctamethylenediamine; C00315; BPBio1_001276; BSPBio_002613; NCGC00024903-01; N-(3-Aminopropyl)-1,4-butane-diamine; 1,4-Butanediamine, N-(3-aminopropyl)-; S0266_SIGMA; CHEBI:16610; Biomol-NT_000212;AKOS024427000; 7712AH; API0004220; 2C7H19N3.3H3O4P; S0385; BG01192050; MFCD00043283; Dispermidine triphosphate; tris(phosphoric acid); bis(spermidine); MCULE-6635730810 | C7H19N3 | 145.25 g/mol | C(CCNCCCN)CN |
| TCMBANKIN057977 | SPM | NSC69852 (TETRAHYDROCHLORIDE); S3256_SIGMA; Diaminopropyltetramethylenediamine; musculamine; 3-aminopropyl-[4-(3-aminopropylamino)butyl]amine; AIDS005222; NSC268508; HSCI1_000212; SPERMINE; 4,9-Diaza-1,12-dodecanediamine; NSC 268508; NCIMech_000206; diaminopropyl-tetramethylenediamine; 4,9-Diazadodecamethylenediamine; N,N'-bis(3-aminopropyl)butane-1,4-diamine; AI3-26633; NCI60_035280; Biomol-NT_000213; gerontine; N,N'-Bis(3-aminopropyl)-1,4-butane-diamine; 71-44-3; 71-44-3 (FREE BASE); BPBio1_001086; 1,4-Bis(aminopropyl) butanediamine; EINECS 200-754-2; Spermine, puriss; NCGC00024902-01; WLN: Z3M4M3Z; N,N'-Bis(3-aminopropyl)-1,4-diaminobutane; BRN 1750791; 306-67-2 (TETRAHYDROCHLORIDE); 1,4-Bis(aminopropyl)butanediamine; 115-04-8; Lopac-S-2876; NSC268508 (FREE BASE); AIDS-005222; Spermine dihydrate; Tocris-0958; 85588_FLUKA; 4-04-00-01301 (Beilstein Handbook Reference); Spermin; Lopac0_001077; C00750; 1,4-Diaminobutane, N,N'-bis(3-aminopropyl)-; NCGC00015941-01; S4264_SIGMA; neuridine; N,N'-Bis(3-aminopropyl)-1,4-butanediamine; 4,9-Diazadodecane-1,12-diamine; NCGC00024902-03; 1,4-Butanediamine, N,N'-bis(3-aminopropyl)-; CHEBI:15746; spermine | C10H26N4 | 202.34 g/mol | C(CCNCCCN)CNCCCN |
| TCMBANKIN058013 | 4-methylene-2-pyrrolidinecarboxylic acid | 4-methylene-dl-proline | C6H9NO2 | 127.14 | C=C1CC(NC1)C(=O)O |
| TCMBANKIN058019 | Tulipane | 226416_ALDRICH; 3-methylene-2-tetrahydrofuranone; tulipalin; 3-methylideneoxolan-2-one; 547-65-9; LMSV-6; Dihydro-3-methylene-2(3H)-furanone; 2(3H)-Furanone, dihydro-3-methylene-; Securolide; .alpha.-Methylene-.gamma.-butyrolactone; alpha-Methylene-gamma-butyrolactone; 66735_FLUKA; AI3-63021; Tulipalin; NSC 205367; alpha-Methylene butyrolactone; AIDS340092; EINECS 208-931-6; .alpha.-Methylene butyrolactone; 3-methylenetetrahydrofuran-2-one; ZINC01740871; 3-methylenedihydrofuran-2(3H)-one; NSC205367; 3-Methylenedihydro-2(3H)-furanone; InChI=1/C5H6O2/c1-4-2-3-7-5(4)6/h1-3H; AIDS-340092; Tulipalin A | C5H6O2 | 98.1 | C=C1CCOC1=O |
| TCMBANKIN058151 | taxifolin | (2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4-chromanone; (2R,3R)-3,3',4',5,7-Pentahydroxyflavanone; (2R,3R)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-4H-1-benzopyran-4-one; 20254-28-8 (DELETED); trans-Dihydroquercetin; ()-Taxifolin; Taxifolin; ZINC00105077; CHEBI:17948; AIDS003061; MEGxp0_000741; 17654-26-1 (DELETED); 3,3′,4′,5,7-Pentahydroxyflavanone; (+)-Taxifolin; MLS000759539; (2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chroman-4-one; (2R,3R)-2-(3,4-DIHYDROXYPHENYL)-3,5,7-TRIHYDROXY-2,3-DIHYDRO-4H-CHROMEN-4-ONE; 78666_FLUKA; MLS001074712; STOCK1N-51590; DQH; T4512_SIGMA; TAXIFOLIN-(+); (2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychroman-4-one; ACon1_000239; (+)-Dihydroquercetin; SMR000466389; 480-18-2; C01617; (2R,3R)-TRANS-DIHYDROQUERCETIN; MLS001066341; AIDS-003061; MLS000759526; AC1LEHLM; NC00093; TAXIFOLIN-(+/-); SCHEMBL1707803; ZINC105086; MLS001423978; (?)-Epitaxifolin; ZB003534; CHEMBL221328; (2R,3S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydro-4H-chromen-4-one; (2R,3S)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromen-4-one; Dihydro quercetin; SMR000499525; CCG-100843; CPD000499525; CHEBI:75747; (-)-epitaxifolin; SAM001246760; AB00698321-05; AJ-11152; HMS2051I06; dihydroquercetin ; (2R,3S)-epitaxifolin; MLS000759526; dihydroquercetin | C15H12O7 | 304.25 g/mol | C1=CC(=C(C=C1C2C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O |
| TCMBANKIN058186 | FA | F8798_SIAL; IDI1_000494; SPECTRUM1502020; KBio1_000494; Folsaure; Acifolic; Prestwick3_000627; Folipac; PGA (VAN); Folsaeure; InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s; Novofolacid [Canada]; KBio2_006997; Folaemin [Netherlands]; Foldine [France]; L-Glutamic acid, N-(4-(((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-; Liver Lactobacillus casei factor; ARONIS014410; Cytofol; Folicet; Foliamin; Folcidin (VAN); Folcidin; Nifolin [Denmark]; Pteroylmonoglutamic acid; L-glutamic acid, N-[4-[[(2-amino-4,8-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-; N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; Antianemia factor; KBioSS_001861; Folico (Italy); Spectrum4_001751; 4-Pteridinol, 2-amino-6-((p-((1,3-dicarboxypropyl)carbamoyl)anilino)methyl)-; C00504; CAS-59-30-3; L-Glutamic acid, N-(4-((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-; BPBio1_000654; Pteroylmonoglutamate; Pteroyl-L-monoglutamic acid; DivK1c_000494; Folbal; Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L; Folic acid [BAN:INN:JAN]; FOL; KBio2_001861; BSPBio_002338; Glutamic acid, pteroyl-, l-; BSPBio_000594; F8758_SIGMA; Vitamin B11; N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid; Vitamin M; CHEBI:27470; KBio2_004429; Folettes; NCGC00016265-01; Vitamin B9; 47620_FLUKA; (2S)-2-[[4-[(2-amino-4-keto-1H-pteridin-6-yl)methylamino]benzoyl]amino]glutaric acid; Factor U; Acidum folicum [INN-Latin]; Spectrum2_001459; Folate; Vitamin Be; Incafolic; Acide folique [INN-French]; Pteroyl-L-glutamic acid; Glutamic acid, N-(p-(((2-amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-, L-; HSDB 2002; N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; D00070; Spectrum3_000749; Folasic (Australia); Mittafol; SMP2_000137; N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; NINDS_000494; Kyselina listova [Czech]; F8890_SIGMA; 59-30-3; AI3-26387; Acido folico [INN-Spanish]; NCGC00142391-01; (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid; Folsav; Folic acid (JP15/USP/INN); KBioGR_002222; Folicet (TN); Folan; CCRIS 666; PteGlu; KBio3_001558; EINECS 200-419-0; Mission Prenatal; Folacid; Spectrum_001381; Folic acid; L-Glutamic acid, N-(4-(((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-; Vitamin Bc; Spectrum5_000602; 33609-88-0; SDCCGMLS-0066738.P001; (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]phenyl]carbonylamino]pentanedioic acid; SPBio_001357; N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid; Folacin; N-pteroyl-L-glutamic acid; Folina (Italy); 01769_FLUKA; Prestwick_230; Acfol (Spain); F7876_SIAL; (2S)-2-[[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]phenyl]-oxomethyl]amino]pentanedioic acid; Folvite; Millafol; Facid | C19H19N7O6 | 441.4 | C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N |
| TCMBANKIN058205 | trans-resveratrol | (E)-1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene; SRT501; AX8004672; DB02709; RP17549; NCGC00017352-05; NCGC00017352-13; NCGC00017352-19; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; 4CN-0696; I06-0437; 3,4',5-Trihydroxy-trans-stilbene; (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; s1396; HMS1990H15; SAM001246888; CPD000058206; CU-01000001503-3; BPBio1_000479; NCGC00024003-14; (E)-5-(p-Hydroxystyryl)resorcinol; FT-0082623; Tox21_501111; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 01R360; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Tox21_303376; MLS001055357; NCGC00024003-13; GP5884; A827984; resveratrol; NCGC00017352-09; NCGC00017352-15; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; NCGC00024003-11; D0U3EP; ACN-034773; ST057251; EU-0101111; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1; HY-16561; N1848; ACT09778; NCGC00017352-17; BRD-K80738081-001-09-6; KUC104385N; 3,4',5-Trihydroxy-trans-stilbene 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol; LUKBXSAWLPMMSZ-OWOJBTEDSA-N; STL; MLS001424228; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzoldiol; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzenediol; HMS1569F17; Resveratrol, Vetec(TM) reagent grade, 98%; HMS1921N04; IDI1_002152; Resvida; KB-02515; SR-01000000163-10; NCGC00017352-08; AB00052942_31; 3,5,4'-Trihydroxystilbene; trans-Stilbene-3,4',5-triol; Tox21_110257; NCGC00024003-12; trans-3,4′,5-Trihydroxystilbene; trans-3,4',5 - trihydroxystilbene; ZB000650; ZINC6787; DSSTox_RID_78898; NCGC00024003-09; 3fts; BB_NC-2570; SRT-501; ZX-AS004941; 5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzol-1,3-diol; BRD-K80738081-001-23-7; trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene; NSC327430; LS-2146; (E)-5-(4-Hydroxystyryl)benzene-1,3-diol; NCGC00024003-04; DSSTox_CID_11980; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3,benzenediol; Prestwick3_000508; trans-Resveratrol, United States Pharmacopeia (USP) Reference Standard; Resveratrol, European Pharmacopoeia (EP) Reference Standard; NCGC00015894-02; ARONIS24568; STL146386; R 5010; 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-; AC1L9HIC; BSPBio_003461; REGID_for_CID_445154; C14H12O3; SR-01000000163-11; 501-36-0; C03582; SRT 501; NSC 327430; NSC-327430; Spectrum5_000552; AS-12413; Trans-3,4′ NCGC00024003-06; AKOS005720936; BG01529320; BBC/741; HMS1792H15; NCGC00258925-01; TL8003323; AB00052942-29; SR-01000000163-4; SR-01000000163-16; BSPBio_000435; Opera_ID_586; NC00349; 1,3-Benzenediol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-; ZX-AT013797; 375823-41-9; HMS3403H15; 3,4',5-Trihydroxystilbene; HMS2232A18; KSC-10-164; AN-865; LMPK13090005; AJ-08292; OR46018; R0071; CHEMBL165; BRD-K25591257-001-01-2; Resveratrol, E-; BBL028252; NCGC00024003-05; LP01111; UNII-Q369O8926L; CCG-38874; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; MFCD00133799; 2l98; BDBM23926; SGCUT00007; GP2549; Resveratrol, trans-; CC-34242; ST2408097; MLS001076538; AK-39118; HMS1362H15; NCGC00024003-07; ABP000376; SBB055452; NCGC00017352-16; trans-3,5,4'-Trihydroxystilbene3,4',5-Stilbenetrioltrans-Resveratrol(E)-5-(p-Hydroxystyryl)resorcinol(E)-5-(4-hydroxystyryl)benzene-1,3-diol; 5-[(1E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; Tox21_110257_1; BRD-K80738081-001-06-2; Resveratrol, certified reference material, TraceCERT(R); 3,4',5-Stilbenetriol; MCULE-5678456463; J10118; BSPBio_001114; HMS2052I09; Resveratrol, >=99% (HPLC); CS-1050; SCHEMBL19425; 5[(E)-2-(4-Hydroxyphenyl)-vinyl]benzene 1,3-diol; Resveratol; (E)1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene; HMS3263O04; 4jaz; AB0006623; CAS-501-36-0; CCRIS 8952; MLS000069735; trans-3,4',5-trihydroxystilbene; 4qer; Tox21_201374; to_000079; SPECTRUM1502223; BC202036; API0000480; NCGC00017352-10; CHEBI:27881; NCGC00017352-24; SY014849; 3,4',5-trihydroxy-stilbene; NCGC00017352-06; PREVENTION 8 (RESVERATROL); MolPort-002-499-801; (E)-resveratrol; BCPP000091; Prestwick_619; 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol; SMR000058206; cid_445154; Q369O8926L; Resveratrol, analytical standard; DSSTox_GSID_31980; NCGC00017352-11; AC-727; HMS2096F17; BS0159; 5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol; BRD-K80738081-001-10-4; NCGC00017352-12; MLS002222231; Resveratrol, natural; Lopac0_001111; BR-39118; CJ-00111; NCGC00017352-07; DTXSID4031980; CR-003; Stilbene, 2f; NCGC00017352-18; NCGC00024003-10; SC-11924; SR-01000000163-3; MLS002207121; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; NCGC00024003-00; HMS3649A20; KS-5047; 1,3-Benzenediol, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-; NCGC00017352-14; HSDB 7571; NCGC00024003-08; 533C1DA0-4104-42B5-9D32-9265F40857E4; RM-1812; REGID_for_CID_6240; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; SDCCGMLS-0002998.P003; BIK9013; NCGC00257465-01; GTPL8741; BG00606847; NCGC00261796-01; CHEBI:45713; SR-01000000163; Resveratrol, synthetic; SR-01000000163-9; Prestwick2_000508; N88795; 3,5,4'-Trihydroxy-trans-stilbene; resveratrol; 1,3-Benzenediol, 5-((1Z)-2-(4-hydroxyphenyl)ethenyl)-; cis-3,5,4'-trihydroxystilbene; AIDS025474; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; SPBio_002356; BPBio1_000479; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Spectrum4_001896; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; EU-0101111; ST057251; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1; resveratrol ; KBioSS_000454; 1684AH; Spectrum3_001821; STL; CHEBI:36002; SPBio_001513; IDI1_002152; Prestwick1_000508; 05F9DB2A-D7E6-4063-8E5B-F7842CF74A5E; 3,5,4'-Trihydroxystilbene; 3,4',5-trihydroxy stilbene; (Z)-resveratrol; 5-[(Z)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; trans-3,4′,5-Trihydroxystilbene; 31100-06-8; 5-[(1Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Cis resveratrol; SRT-501; NSC327430; 3,4′,5-Trihydroxy-trans-stilbene; Spectrum_001148; 5-[(1Z)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; NCGC00024003-04; Prestwick3_000508; NCGC00015894-02; Z-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; NCGC00017352-03; SCHEMBL1931746; 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-; BSPBio_003461; Bio2_000877; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1-; 31100-06-8 (DELETED); Z-Resveratrol; UNII-AUA0K06FSB; 501-36-0; C03582; AKOS025395422; KBio2_004196; KBio3_002965; Prestwick0_000508; NSC 327430; 34092_RIEDEL; KBio3_000848; NCGC00017352-02; Spectrum5_000552; MolPort-003-850-143; NCGC00024003-06; KBio2_005590; SpecPlus_000391; AC1LU7HY; AUA0K06FSB; KBioGR_000454; AIDS-025474; BSPBio_000435; cis-resveratrol; KBio2_006764; KBio2_001628; KBioGR_002457; CHEMBL87333; 3,4',5-Trihydroxystilbene; Lopac-R-5010; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; KBio2_000454; Resveratrol, (Z)-; SGCUT00007; CJ-13797; NCGC00024003-07; Resveratrol (Z)-form [MI]; NCGC00017352-01; I14-7425; DivK1c_006487; MolMap_000045; 3,4',5-Stilbenetriol; Oprea1_727238; Tocris-1418; DB-072954; NCGC00017352-04; BSPBio_001114; BDBM50131698; 434C671; LUKBXSAWLPMMSZ-UPHRSURJSA-; KBio3_000847; CAS-501-36-0; SMP1_000257; 4q93; MLS000069735; cis-5-[2-(4-Hydroxyphenyl)ethenyl]benzene-1,3-diol; ZINC00006787; (Z)-3,5,4'-trihydroxystilbene; to_000079; SPECTRUM1502223; trans-Resveratrol; R5010_SIGMA; KBio2_003022; 61434-67-1; NCGC00024003-02; NCGC00015894-01; CHEBI:27881; Resveratrol; AC-24235; (E)-resveratrol; Prestwick_619; 5-[2-(4-hydroxyphenyl)vinyl]resorcinol; SMR000058206; TNP00294; Resveratrol, Z-; ZINC12353732; Lopac0_001111; cis-3,4',5-trihydroxystilbene; NCI60_002840; 5-[(E)-2-(4-hydroxyphenyl)vinyl]resorcinol; Bio2_000397; NCGC00024003-00; (Z)-3,4',5-trihydroxystilbene; 3,5-Dihydroxy-4'-methoxystilbene; 3, 5,4'-trihydroxy-trans-stilbene; cis-3,4,5-Trihydroxystilbene; NCGC00024003-08; RM-1812; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; 5-[2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; SDCCGMLS-0002998.P003; KBioSS_001628; KBio1_001431; 5-[(Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; CHEBI:45713; Spectrum2_001497; Prestwick2_000508; 3,5,4'-Trihydroxy-trans-stilbene | C14H12O3 | 228.24 g/mol | C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O |
| TCMBANKIN058213 | kaemferol;kampferol;kaempferol;campherol | TNP00039; nchembio.2007.28-comp30; Kaempherol; 5-18-05-00251 (Beilstein Handbook Reference); Prestwick2_001098; CHEBI:28499; Prestwick1_001098; CAS-520-18-3; BRN 0304401; Flavone, 3,4',5,7-tetrahydroxy-; ST030560; MEGxp0_001283; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-5,7,4'-Trihydroxyflavonol; C.I. 75640; Swartziol; K0133_SIGMA; kaempferol oxoanion; NCGC00016480-01; 60010_FLUKA; EINECS 208-287-6; Pelargidenon; Nimbecetin; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4-chromenone; NSC 407289; 3,4',5,7-Tetrahydroxyflavone; HSCI1_000027; Pelargidenolon 1497; NSC407289; Robigenin; C05903; CPD1F-90; Kampferol; NSC 656277; Prestwick0_001098; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one; Populnetin; Kampcetin; Prestwick3_001098; AIDS-001404; ZINC00137345; kaempferol ; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-olate; 3,4′,5,7-Tetrahydroxyflavone; Rhamnolutein; NCGC00016480-02; ACon1_001867; NSC656277; 3,4′,5,7-Tetrahydroxyflavone; BSPBio_001176; SPBio_003058; Oprea1_650954; 5,7,4'-Trihydroxyflavonol; 4H-1-Benzopyran-4-one,3,5,7-trihydroxy-2-(4-hydroxyphenyl)-5,7,4'-Trihydroxyflavonol; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- (9CI); Campherol; 520-18-3; 3,5,7-TRIHYDROXY-2-(4-HYDROXYPHENYL)-4H-CHROMEN-4-ONE; S00111; Trifolitin; Kampherol; AI3-36096; 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromone; Indigo yellow; Pelargidenolon; AIDS001404; nchembio718-comp14; NCGC00091036-01; Flavone, 3,4',5,7-tetrahydroxy- (7CI,8CI); CHEBI:58573; Kaemferol; Kempferol; BPBio1_001294; 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; Rhamnolutin; 3,5,7-triOH-Flavone; KMP; CCRIS 41; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)- | C15H10O6 | 286.24 g/mol | C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O |
| TCMBANKIN058435 | pyrrole-2-aldehyde;2-Formylpyrrole | Pyrrole-2-carboxaldehyde, 98%; DB-030991; CTK0H4910; AC1L22MH; 1H-Pyrrole-2-carbaldehyde #; AN-29312; Methanol, 1-(2H-pyrrol-2-ylidene)-; A-4046; TRA0018876; Pyrrole-2-carbaldehyde; RTC-020750; PS-9355; F0001-2423; MCULE-4586543663; 1H-Pyrrolecarboxaldehyde; BC210794; AS06197; BBL022920; 03P298; PubChem9140; 1H-pyrrole-2-carboxyaldehyde; Pyrrole-2-aldehyde; 82655-EP2298758A1; BB_SC-4628; AKOS000120434; BR-25235; CJ-04708; CS-D0925; SBB004389; P1246; A16168; pyrrol-2-aldehyde; CHEBI:59978; ACT05084; NSC-66394; 2-PCA; PYRROLE-2-CARBOXALDEHYDE; 1003-29-8; alpha-Pyrrolaldehyde; 254729-95-8; AB1001210; .alpha.-Pyrrolaldehyde; RW1987; MFCD00005217; 2-Pyrrolylcarboxaldehyde; NSC-112885; 2-pyrrole aldehyde; STR01055; ACMC-1CF29; 2-pyrrolcarboxaldehyde; 82655-EP2305664A1; Pyrrol-2-carboxaldehyde; AC1Q6PVO; TL80073583; KSC174S1B; ST056382; HTS027704; 129006-63-9; 6719/3/5; Pyrrole-2-carboxaldehyde (8CI); 2-carboxaldehyde-1H-pyrrole; ANW-14239; CHEMBL2229658; 2-pyrrole carbaldehyde; STK320567; Z1741970067; CM13861; 2-Formyl-1H-pyrrole; EINECS 213-705-5; pyrrole-carboxaldehyde; LS00119; BG00599833; DTXSID3061392; Q-101975; 1( H)-Pyrrole carboxaldehyde; AM20070639; ZSKGQVFRTSEPJT-UHFFFAOYSA-N; NSC 66394; 068TSM6S6P; 2-Pyrrolaldehyde; 1(H)-pyrrole carboxaldehyde; MolPort-000-142-353; AN-12118; formyl-pyrrole; KB-60220; SC-29059; 1H-Pyrrole-2-carbaldehyde; NSC112885; Pyrrole-2-carboxaldehyde, 99% 5g; AB00388; FT-0603764; AJ-24848; UNII-068TSM6S6P; ST2408936; 2-Pyrrolcarbaldehyde; ZB015828; TC-020750; 82655-EP2298759A1; InChI=1/C5H5NO/c7-4-5-2-1-3-6-5/h1-4,6; 82655-EP2281822A1; AI3-35104; 2-Formylpyrrole; pyrrole carboxaldehyde; RP00378; FT-0660920; 1-Pyrrole-2-carboxaldehyde; PYRROLO-2-CARBOXALDEHYDE; BRD-K20608729-001-01-9; SC-00019; Epitope ID:136032; 2-Pyrrolecarboxaldehyde; BP-10720; I11-0010; NSC 112885; pyrrole aldehyde; ZINC1069171; NSC66394; AK-25235; 2-Pyrrolecarbaldehyde; AC-4316; pyrrol-2-carbaldehyde; pyrrole 2-carboxaldehyde; 2-Formyl-pyrrole; Jsp000093; QC-480; 1H-Pyrrole-2-carboxaldehyde | C5H5NO | 95.1 g/mol | C1=CNC(=C1)C=O |
| TCMBANKIN058450 | ADO | nchembio.2007.56-comp13; CHEBI:16335; Bio1_000437; 9-beta-D-Ribofuranosyl-9H-purin-6-amine; AIDS-001224; 9beta-D-Ribofuranosyladenine; BSPBio_001796; beta-Adenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol; beta-D-Ribofuranoside, adenine-9; D00045; 46969-16-8; SDCCGMLS-0003108.P003; 4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 6-Amino-9-.beta.-ribofuranosyl-9H-purine; NSC 7652; Bio1_001415; Adenosine (JAN/USP); Spectrum2_001257; Spectrum3_000288; Adenosine, homopolymer; ADN; Caswell No. 010B; Adenocard; C00212; SR 96225; Adenocard (TN); EINECS 200-389-9; KBio3_001296; 9H-Purin-6-amine, 9beta-D-ribofuranosyl-; Polyadenosine; beta-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-; (2R,3R,4S,5R)-2-(6-amino-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; MLS000069638; AI3-52413; 9-beta-D-Ribofuranosidoadenine; A9251_SIGMA; Adenoscan (TN); Bio1_000926; ZINC02169830; CCRIS 2557; NCGC00023673-05; Ade-Rib; nchembio706-5; 30143-02-3; 6-Amino-9-beta-D-ribofuranosyl-9H-purine; Adenosin [German]; NSC 627048; SMR000058216; 9-beta-D-Ribofuranosyladenine; SPBio_001194; beta-D-Adenosine; Adenosine [USAN:BAN]; Polyriboadenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; AIDS001224; 6-Amino-9beta-D-ribofuranosyl-9H-purine; ST009496; Adenoscan; A4036_SIGMA; SPECTRUM1500107; 46946-45-6;SCHEMBL170902; adenosine ; AKOS015960342; AC-5504; BC200893; Adenosine;adenosine;adeninenucleoside | C10H13N5O4 | 267.24 g/mol | C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N |
| TCMBANKIN058471 | fructose;D-fructose | SCHEMBL16930344 | C6H12O6 | 180.16 g/mol | C1C(C(C(C(O1)(CO)O)O)O)O |
| TCMBANKIN058520 | catechin c;epicatechin;alpha-catechin;(-)epicatechin | epi-Catechol; (3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; SCHEMBL13350313; Epicatechin; (.+-.)-Epicatechol; (+/-)-Epicatechin; AC1L5SMJ; L-Epicatechin; Epicatechol, (-)-; 17334-50-8; NSC-81162; 2H-1-Benzopyran-3,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)-; epicatechin ; NSC81162; (3R)-2-(3,4-DIHYDROXYPHENYL)-3,4-DIHYDRO-2H-1-BENZOPYRAN-3,5,7-TRIOL; 2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3alpha,5,7-triol; NSC-81161; NSC81161;EINECS 207-710-1; KBio2_003207; SpecPlus_000267; (+/-)-Epicatechin; SMP1_000115; AIDS-001347; NSC81161; STOCK1N-16439; (-)-epicatechin; KBioGR_001538; NSC 81161; .alpha. Catechin; BCBcMAP01_000224; KBio1_001307; 2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R,3R)-; CCRIS 7097; 2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)- (9CI); C09727; (- )-epicatechin; KBio2_005775; Spectrum3_000243; KBioSS_000639; NCGC00015215-01; (-)-Epicatechin; 2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3alpha,5,7-triol; 17334-50-8; ZINC00119988; (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3,5,7-triol; SCHEMBL13350313; (-)- epicatechin; (3R)-2-(3,4-DIHYDROXYPHENYL)-3,4-DIHYDRO-2H-1-BENZOPYRAN-3,5,7-TRIOL; (.+-.)-Epicatechol; E4018_SIGMA; CHEBI:28466; NSC81162; Spectrum4_000949; 525952_ALDRICH; NSC-81162; DivK1c_006363; 2545-08-6; (-)-(2R:3R)-5,7,3',4'-Tetrahydroxyflavan-3-ol; (−)-Epicatechin; AC1L5SMJ; Lopac-C-1251; NCGC00016415-02; (2R,3R)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol; (3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; Spectrum5_000929; l-Acacatechin; AIDS001347; E1753_SIGMA; 39263_FLUKA; (-)epicatechin ; Epicatechin; 2H-1-Benzopyran-3,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)-; Spectrum2_000675; 490-46-0; KBio3_001126; KBio2_000639; Prestwick_203; (−)-cis-3,3′,4′,5,7-Pentahydroxyflavane; NCGC00016415-01; (-)-epicatechin ; Epicatechin-(-); SDCCGMLS-0066927.P001; CAS-7295-85-4; (- )- epicatechin; 2-(3,4-Dihydroxyphenyl)-2,3,4-trihydro-3,5,7-trihydroxychromene; SPBio_000769; L-Epicatechin; epi-Catechol; Oprea1_209947; NSC-81161; (-) epicatechin; SPECTRUM210206; BSPBio_001626; (2R,3R)-(-)-Epicatechin; Spectrum_000159; (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; epi-Catechin; CAS-154-23-4; ACon1_001106; Epicatechol, (-)- | C15H14O6 | 290.27 | C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O |
| TCMBANKIN058716 | β-selinene | ZINC8234293; (4aR,7R,8aS)-4a-methyl-1-methylidene-7-(prop-1-en-2-yl)decahydronaphthalene eudesma-4(14),11-diene; .beta.-Eudesmene; CHEBI:10443; YOVSPTNQHMDJAG-QLFBSQMISA-N; Eudesma-4(14),11-diene; (4aR,7R,8aS)-4a-methyl-1-methylidene-7-(prop-1-en-2-yl)decahydronaphthalene; (4aR,7R,8aS)-7-isopropenyl-4a-methyl-1-methylenedecahydronaphthalene; beta-selinene; CHEMBL2287242; beta-Selinene; eudesemene; 17066-67-0; beta-Eudesmene; BETA-SELINENE; beta-selinene ; (4aR,7R,8aS)-7-isopropenyl-4a-methyl-1-methylene-decalin; (4aR,7R,8aS)-7-isopropenyl-4a-methyl-1-methylenedecalin; beta-selinene ; β- Selinene; (+)-beta-Selinene; (3R,4aS,8aR)-8a-methyl-5-methylidene-3-prop-1-en-2-yl-1,2,3,4,4a,6,7,8-octahydronaphthalene; .beta.-Selinene; [4aR-(4aalpha,7alpha,8abeta)]-decahydro-4a-methyl-1-methylene-7-(1-methylethenyl)-naphthalene; 7-Isopropenyl-4a-methyl-1-methylenedecahydronaphthalene-, (4aR-(4a.alpha.,7.alpha.,8a.beta.))-; (4ar,7r,8as)-decahydro-4a-methyl-1-methylene-7-(1-methylethenyl)-naphthalene; AC1L9CQH; (+)-.beta.-Selinene; LMPR0103190014; C09723; Naphthalene, decahydro-4a-methyl-1-methylene-7-(1-methylethenyl)-, [4aR-(4a.alpha.,7.alpha.,8a.beta.)]-;eudesma-4(14),11-diene; Eudesma-4(14), 11-diene;b-selinene;Eudesma-4(14),11-diene;Selinene;(4aS,7S,8aR)-7-isopropenyl-4a-methyl-1-methylenedecalin;(4aS,7S,8aR)-7-isopropenyl-4a-methyl-1-methylene-decalin; 18423-23-9; Naphthalene, decahydro-4a-methyl-1-methylene-7-(1-methylethenyl)-, (4aR-(4aalpha,7alpha,8abeta))-; (3S,4aR,8aS)-8a-methyl-5-methylidene-3-prop-1-en-2-yl-1,2,3,4,4a,6,7,8-octahydronaphthalene | C15H24 | 204.35 g/mol | CC(=C)C1CCC2(CCCC(=C)C2C1)C |
| TCMBANKIN058718 | neointermedeol | C15H26O | 222.37 g/mol | CC(=C)C1CCC2(CCCC(C2C1)(C)O)C | |
| TCMBANKIN058726 | selina-4(15),7(11)-diene | eudesma-4-(14), 7(11)diene; Gamma-Selinene; eudesma-4(14),7(11)-diene; (4aR-trans)-Decahydro-4a-methyl-1-methylene-7-(1-methylethylidene)naphthalene; CHEBI:138051; gamma-selinene; Selina-4(15),7(11)-diene; 515-17-3; C21707; Selina-4(14),7(11)-diene; (4aR,8aS)-4a-methyl-1-methylidene-7-(propan-2-ylidene)decahydronaphthalene; RMZHSBMIZBMVMN-LSDHHAIUSA-N; Eudesma-4(14),7(11)-diene | C15H24 | 204.35 g/mol | CC(=C1CCC2(CCCC(=C)C2C1)C)C |
| TCMBANKIN058762 | ginsenoside Rh4 | ginsenoside rh 4; ginsenosiderh4 | C36H60O8 | 620.86 | CC(=CCC=C(C)C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)C |
| TCMBANKIN058763 | ginsenosiderh3 | ginsenoside rh 3 | C36H60O7 | 604.9 g/mol | CC(=CCC=C(C)C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)C |
| TCMBANKIN058764 | ginsenoside ic | C42H70O12 | CC(=CCC=C(C)C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)C | ||
| TCMBANKIN058854 | protopanaxtriol | (3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol | C30H52O4 | 476.73 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)O)C)O)C)O)C |
| TCMBANKIN058855 | ginsenoside f1 | (2S,3R,4R,5S,6R)-2-[(1R)-1,5-dimethyl-1-[(6R,10R,12S,13R,14R,17S)-3,6,12-trihydroxy-4,4,10,14,17-pentamethyl-2,3,5,6,7,8,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hex-4-enoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; AC1L4RUP; AN-40678; (2R,3S,4R,5R,6S)-2-(hydroxymethyl)-6-[(2R)-6-methyl-2-[(6R,10R,12S,13R,14R,17S)-3,6,12-trihydroxy-4,4,10,14,17-pentamethyl-2,3,5,6,7,8,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol; ginsenoside-F1 | C36H62O9 | 638.9 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)O)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C |
| TCMBANKIN058857 | ginsenoside-Rh1 | MolPort-019-999-714; CS-3834; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-oxidanyl-hept-5-en-2-yl]-3,12-bis(oxidanyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]oxane-3,4,5-; 20(S)-Ginsenoside Rh1; MFCD09951797; Ginsenoside Rh1, analytical standard; AKOS025311542; Ginsenoside Rh1; Ginsenoside Rg1 metabolite; (3beta,6alpha,12beta)-3,12,20-Trihydroxydammar-24-en-6-yl-beta-D-glucopyranoside; ginsenoside-rh1; ginsenoside- Rh1; 20(R)-Ginsenoside-Rh1; HY-N0604; Q-100729; 63223-86-9; A834283; BDBM50023447; 20(R)-ginsenoside Rh1; ZINC49852137; (2R,3R,4S,5S,6R)-2-{[(1S,3AR,3BR,5S,5AR,7S,9AR,9BR,11R,11AR)-7,11-DIHYDROXY-1-[(2S)-2-HYDROXY-6-METHYLHEPT-5-EN-2-YL]-3A,3B,6,6,9A-PENTAMETHYL-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-5-YL]OXY}-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL; C36H62O9; O581; BIDD:ER0183; CHEMBL466844; (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol;20r -ginsenoside rh1 | C36H62O9 | 638.87g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)O)C |
| TCMBANKIN058858 | ginsenoside- Rg1 | ginsenoside-rg1;(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1,5-dimethyl-1-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]hex-4-enyl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H; (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a; (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1,5-dimethyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-hex-4-enyl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclop; (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[; C08946; (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1,5-dimethyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-hex-4-enyl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-; 22427-39-0; sanchinoside rg1; Sanchinoside C1 | C42H72O14 | 801.01 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)OC6C(C(C(C(O6)CO)O)O)O)C |
| TCMBANKIN058859 | Notoginsenoside R6 | notoginsenoside r6 | C48H82O19 | 963.2 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)OC6C(C(C(C(O6)COC7C(C(C(C(O7)CO)O)O)O)O)O)O)C |
| TCMBANKIN058860 | ginsenoside rf | 2α,3β,12β,20(s)-3-hydroxydammar-24-en-20-o-β-d-glucopyranoside; (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-; C08945; (2S,3R,4S,5S,6R)-2-[[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-; ginsenoside r f; ginsenoside-rf; Ginsenoside Rf; (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-; ginsenosiderf; 52286-58-5; (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6 | C42H72O14 | 801.01 | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)O)C |
| TCMBANKIN058861 | ginsenoside rd;20-glucosylginsenosiderf;20-glucosylginsenosiderf | ginsenoside-rd; ginsenosiderd; A829210; 2-(hydroxymethyl)-6-[6-(hydroxymethyl)-2-[[17-[2-[6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-3,12-bis(oxidanyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-b; 2-[[2-[[3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[6-methyl-2-[[3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]hept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)-3-oxanyl]oxy]-6;(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(6S,14R)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; 20-glucosylginsenoside rf; AC1O3DDF;;20-glucosylginsenosiderf;20-glucosylginsenosiderf | C48H82O18 | 947.15 | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)CO)O)O)O)C |
| TCMBANKIN058864 | 20-(R)-ginsenoside Rh2 | 20(R)-Ginsenoside-Rh2 | C36H62O8 | 622.87g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C |
| TCMBANKIN058866 | 20-(S)-Ginsenoside-Rg3 | 20-(s)-ginsenoside-rg3; 20(S)-ginsenoside Rg3; 20(S)- ginsenoside-Rg3; 20(s)-ginsenosiderg3 | C42H72O13 | 785.01 | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)O)C |
| TCMBANKIN058867 | ginsenoside rb1 | Q-100470; A-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl ; GRb 1; MFCD00133367; ginsenosiderb1; Ginsenoside-Rb1 from Panax ginseng (Korean ginseng) root, triterpenoid saponin; beta-D-Glucopyranoside, (3-beta,12-beta)-20-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-; N1620; NSC 310103; CHEBI:67989; Ginsenoside Rb1, primary pharmaceutical reference standard; C20713; Panax saponin E; 7413S0WMH6; Pseudoginsenoside D; 87700-07-0; A-Glucopyranosyl-(3; C54H92O23; A)-20-[(6-O-; 2-O-beta-Glucopyranosyl-(3beta,12beta)-20-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl-beta-D-glucopyranoside; Ginsenoside Rb1, European Pharmacopoeia (EP) Reference Standard; (3beta,12beta)-20-{[6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; 20(S)-ginsenoside Rb1; 2-O-; Ginsenoside Rb1 (saponin of panax ginseng); 52286-61-0; 12770-17-1; 393829-67-9; CS-3829; BIDD:ER0108; A,12; 2-O-beta-Glucopyranosyl-(3beta,12beta)-20-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl beta-D-glucopyranoside; GZYPWOGIYAIIPV-JBDTYSNRSA-N; Ginsenoside-Rb1 from Panax ginseng (Korean ginseng) root; GS-Rb1; 41753-43-9; ginsenoside-rb1; ginsenoside r b1; 212055-66-8; UNII-7413S0WMH6; AB0016710; AKOS025311537; A-D-glucopyranoside; Ginsenoside rb1; MolPort-016-638-397; gensenoside Rb1; Gypenoside III; ginsenoside Rb1; CHEMBL501515; HY-N0039; Gynosaponin C; BDBM50317541; (3beta,12beta)-20-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; Ambap41753-43-9; GSRb1; Ginsenoside-Rb1; 753G439; Sanchinoside E1; A-D-glucopyranosyl-; Panaxsaponin E; O899; ginsenoside-Rb1;gypenosideIII | C54H92O23 | 1109.3 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)C |
| TCMBANKIN058868 | Ginsenoside-Ra3 | ginsenoside-ra3;ginsenoside ra 3 | C59H100O27 | 1241.41 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)OC9C(C(C(CO9)O)O)O)O)O)O)O)C |
| TCMBANKIN058869 | ginsenoside Rb3 | ginsenoside rb3; ginsenoside r b3; gensenoside- Rb3; ginsenoside- Rb3; gensenoside Rb3; ginsenosiderb3; ginsenoside-rb3 | C53H90O22 | 1079.3 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C |
| TCMBANKIN058870 | ginsenosidera1 | ginsenoside ra1; Ginsenoside-Ra1 | C58H98O26 | 1211.4 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)OC9C(C(C(CO9)O)O)O)O)O)O)O)O)C |
| TCMBANKIN058871 | Ginsenoside-Ra2 | ginsenoside-ra2;ginsenoside r a2;ginsenosidera2 | C58H98O26 | 1211.4 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(O8)CO)O)OC9C(C(C(CO9)O)O)O)O)O)O)C |
| TCMBANKIN058872 | ginsenosidera0 | Ginsenoside-Ra0;ginsenoside ra 0 | C60H102O28 | 1271.4 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(C(O7)CO)O)O)O)C)C)O)C)OC8C(C(C(C(O8)COC9C(C(C(C(O9)CO)O)O)O)O)O)O)C |
| TCMBANKIN058874 | Ginsenoside-Rs1 | ginsenoside-rs1 | C55H92O23 | 1121.31 | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)COC(=O)C)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C |
| TCMBANKIN058875 | Malonylginsenoside Rd | malonylginsenosiderd; malonyl ginsenoside Rd; malonylginsenoside rd | C51H84O21 | 1033.2 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)COC(=O)CC(=O)O)O)O)O)C)C)O)C)OC7C(C(C(C(O7)CO)O)O)O)C |
| TCMBANKIN058877 | malonylginsenosiderb2 | malonylginsenoside rb2 | C56H92O25 | 1165.3 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)COC(=O)CC(=O)O)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C |
| TCMBANKIN058878 | ginsenosiders2 | ginsenoside rs 2 | C55H92O23 | 1121.3 g/mol | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)COC(=O)C)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(O8)CO)O)O)O)O)O)C |
| TCMBANKIN058892 | alpha-santalol | Santalol, cis,α-;alpha.-Santalol;2-Penten-1-ol, 5-(2,3-dimethyltricyclo(2.2.1.02,6)hept-3-yl)-2-methyl-, stereoisomer; SCHEMBL14363250; 2-Penten-1-ol, 5-(2,3-dimethyltricyclo(2.2.1.0(2,6))hept-3-yl)-2-m; EINECS 204-102-8; 5-(2,3-Dimethyltricyclo(2.2.1.0(2,6))hept-3-yl)-2-methyl-2-penten-1-ol; α-Santalol; LS-102120; Cis-a-Santalol; 2-Penten-1-ol, 5-(2,3-dimethyltricyclo(2.2.1.0(sup 2,6))hept-3-yl)-2-methyl-, (R(Z))-; Argeol; 5-(2,3-Dimethyltricyclo(2.2.1.02,6)hept-3-yl)-2-methyl-2-penten-1-ol stereoisomer; Santalol, alpha-; α-santalol; Arheol; d-alpha-Santalol; cis-alpha-Santalol; ALPHA-SANTALOL; 5-(2,3-Dimethyltricyclo(2.2.1.02,6)hept-3-yl)-2-methylpent-2-en-1-ol, stereoisomer; 2-Penten-1-ol, 5-(2,3-dimethyltricyclo(2.2.1.0(sup 2,6))hept-3-yl)-2-methyl; HSDB 3421; (Z)-alpha-Santalol | C15H24O | 220.35 | CC(=CCCC1(C2CC3C1(C3C2)C)C)CO |
| TCMBANKIN058894 | santalol | α-santalol; (Z)-2-methyl-5-[(1S, 2R, 4R)-2-methyl-3-methylene-2-norbornanyl]pent-2-en-1-ol; (Z)-2-methyl-5-[(1S, 4R, 6R)-6-methyl-5-methylidene-6-bicyclo[2.2.1]heptanyl]pent-2-en-1-ol; (2Z)-2-methyl-5-[(1S, 2R, 4R)-2-methyl-3-methylidenebicyclo[2.2.1]hept-2-yl]pent-2-en-1-ol; (Z)-2-methyl-5-[(1S, 2R, 4R)-2-methyl-3-methylene-norbornan-2-yl]pent-2-en-1-ol; CHEBI:10441; (Z)-beta-santalol; 2-Penten-1-ol, 2-methyl-5-(2-methyl-3-methylene-2-norbornyl)-; beta-Santalenol; 37172-31-9; (1S-(1alpha, 2alpha(Z), 4alpha))-2-Methyl-5-(2-methyl-3-methylenebicyclo(2.2.1)hept-2-yl)-2-penten-1-ol; beta-santalol; CHEBI:10441; cis-beta-santalol; Santalol, beta-; 2-Penten-1-ol, 2-methyl-5-(2-methyl-3-methylenebicyclo(2.2.1)hept-2-yl)-, (1S-(1alpha, 2alpha(Z), 4alpha))-; UNII-1DGG9VW8SA | C15H24O | 220.35 g/mol | CC(=CCCC1(C2CCC(C2)C1=C)C)CO |
| TCMBANKIN058923 | paeonol | CBiol_000986; 2′-Hydroxy-4′-methoxyacetophenone; KBio3_002432; SPBio_002161; InChI=1/C9H10O3/c1-6(10)8-4-3-7(12-2)5-9(8)11/h3-5,11H,1-2H; Spectrum3_001686; 1-(2-hydroxy-4-methoxy-phenyl)ethanone; paeonol ; H35803_ALDRICH; ST5331356; NCGC00095977-01; SPECTRUM1601021; AIDS-002237; AIDS002237; Resacetophenone-4-methyl ether; 2-Hydroxy-4-methoxyacetophenone; Spectrum2_001981; Paeonol; 1-(2-Hydroxy-4-methoxyphenyl)ethanone; AI3-10581; BSPBio_003212; Peonol; 4-08-00-01793 (Beilstein Handbook Reference); C10712; 1-[2-hydroxy-4-(methyloxy)phenyl]ethanone; 2-Acetyl-5-methoxy-phenol; Acetophenone, 2'-hydroxy-4'-methoxy- (7CI,8CI); NSC 401442; Paeonal; SDCCGMLS-0066845.P001; ZINC00001906; Resacetophenone, 4-O-methyl ester; Ethanone, 1-(2-hydroxy-4-methoxyphenyl)-; 4-O-Methylresacetophenone; Acetophenone, 2'-hydroxy-4'-methoxy-; 2-hydroxy-4-methoxyacetophenone; 2'-Hydroxy-4'-methoxyacetophenone; ICCB4_000282; BRN 1282794; EINECS 209-012-2; Ethanone, 1-(2-hydroxy-4-methoxyphenyl)- (9CI); 552-41-0; 2'-hydroxy-4'-methoxyacetophenone; NSC401442; KBio3_002432; Paeonol (Peonol); CHEMBL1079227; SPECTRUM1601021; AKOS000119646; RTC-067540; M-2917; UILPJVPSNHJFIK-UHFFFAOYSA-N; Resacetophenone-4-methyl ether; BBL012127; 1-(2-Hydroxy-4-methoxyphenyl)ethanone; ST45027685; 1-(2-hydroxy-4-methoxyphenyl)ethane-1-one; UNII-3R834EPI82; Resacetophenone, 4-O-methyl ester; 4CN-0677; SR-05000002397-1; EINECS 209-012-2; FT-0618875; 2-acetyl-5-methoxyphenol; Ethanone, 1-(2-hydroxy-4-methoxyphenyl)- (9CI); 552-41-0; AC1Q48VO; TRA0005840; SY013508; MCULE-2846207321; Paeonolum; 1-(2-hydroxy-4-methoxyphenyl)-ethanone; AB0044007; MolPort-001-537-637; SCHEMBL1449478; CCG-39471; AN-1408; 2;-Hydroxy-4;-methoxyacetophenone; CP0063; KSC490C8B; HMS3656E07; C10712; 1-[2-hydroxy-4-(methyloxy)phenyl]ethanone; AC1Q48VN; ACN-027221; SDCCGMLS-0066845.P001; KB-146762; FT-0602529; MLS006011902; CHEBI:69581; SMR000112386; Acetophenone, 2'-hydroxy-4'-methoxy-; 2'-Hydroxy-4'-methoxyacetophenone; CTK3J0180; AM20040702; BB_SC-2796; CBiol_000986; BRD-K94239562-001-02-2; InChI=1/C9H10O3/c1-6(10)8-4-3-7(12-2)5-9(8)11/h3-5,11H,1-2H; AS05193; Q-100626; 1-(2-Hydroxy-4-methoxyphenyl)ethanone #; HY-N0159; STK078097; I06-0541; MFCD00008730; NSC-401442; 3R834EPI82; KS-000004VU; PubChem3271; AK-79421; SR-05000002397; 1-(2-hydroxy-4-methoxy-phenyl)-ethanone; TC-067540; 4-Methoxy-2-hydroxyacetophenone; Acetophenone, 2'-hydroxy-4'-methoxy- (7CI,8CI); LS-101156; AJ-08110; 552H410; Paeonal; NSC 401442; SC-05288; N1847; 1-(2-hydroxy-4-methoxyphenyl)ethan-1-one; BDBM50310718; AS-15489; 4-O-Methylresacetophenone; NCGC00095977-02; ICCB4_000282; ACT07801; NSC401442; SPBio_002161; AC1L1WLK; Spectrum3_001686; 1-(2-hydroxy-4-methoxy-phenyl)ethanone; 4-methoxy 2-hydroxy acetophenone; ACMC-209lls; s2339; ST24021015; NCGC00095977-01; PAEONOL; ANW-32270; 2-HYDROXY-4-METHOXYACETOPHENONE (4,4,4-D3); 2-Hydroxy-4-methoxyacetophenone; Spectrum2_001981; AI3-10581; BSPBio_003212; Peonol; 4-08-00-01793 (Beilstein Handbook Reference); 2-Acetyl-5-methoxy-phenol; 1-acetyl-2-hydroxy-4-methoxybenzene; NCGC00095977-03; CJ-00070; Ethanone, 1-(2-hydroxy-4-methoxyphenyl)-; DTXSID1022059; AC-7982; BRN 1282794; SBB066134; ZINC1906; ACN-S003528; 4'-Methoxy-2'-hydroxyacetophenone; 1-(4-Methoxy-2-hydroxy-phenyl)-ethanone; RP02462; P565; 2'-Hydroxy-4'-methoxyacetophenone, 99%; ethanone,1-(2-hydroxy-4-methoxyphenyl)-; peonol; Ethanone,1-(2- Hydroxy- 4- methoxyphenyl); 1-(2-hydroxy-4-methoxyphenyl)-ethanone; paeonal | C9H10O3 | 166.17 g/mol | CC(=O)C1=C(C=C(C=C1)OC)O |
| TCMBANKIN059091 | ditertbutyl phthalate | Di-(terc-butilperoxi)ftalato; 30448-43-2; SCHEMBL109178; DTXSID10184527; EINECS 250-204-0; benzene-1,2-dicarboxylic acid ditert-butyl ester; Diperoxyphtalate de tert-butyle; 1,2-Benzenedicarboxylicacid, 1,2-bis(1,1-dimethylethyl) ester; AC1L3T9P; ditertbutyl phthalate; AKOS030616148; CTK4G5219; AK661164; Phthalic acid ditert-butyl ester; Peroxyphthalic acid, di-tert-butyl ester (8CI); Di-(tert-butylperoxy) phthalate, >55% in solution; AC1Q5XKL; ditert-butyl benzene-1,2-dicarboxylate; ZINC5353715; Di-tert-butyl phthalate; ACM30448432; 1,2-DI-TERT-BUTYL PHTHALATE; 134115-67-6 | C16H22O4 | 278.34 | CC(C)(C)OC(=O)C1=CC=CC=C1C(=O)OC(C)(C)C |
| TCMBANKIN059175 | delta-elemene | delta-Elemene; g-elemene; cyclohexene,4-ethenyl-4-methyl-3-[1-methylethenyl]-1-[1-methylethyl]-; δ- elemene | C15H24 | 204.35 | CC(C)C1=CC(C(CC1)(C)C=C)C(=C)C |
| TCMBANKIN059262 | diisocapryl phthalate;Diop;diisooctyl phthalate;1,2-benzenedicarboxylic acid,diisooctyl ester | HSDB 588; 1,2-Benzenedicarboxylic acid, diisooctyl ester; bis(6-methylheptyl) benzene-1,2-dicarboxylate; Diisocapryl phthalate; EINECS 248-523-5; Diisooctyl phthalate; 71097-28-4; Phthalic acid, bis(6-methylheptyl)ester; Phthalic acid, diisooctyl ester; AI3-27697-X (USDA); 27554-26-3; Diisooctyl 1,2-benzenedicarboxylate; 1330-91-2; NSC 6381; Di-iso-octyl phthalate; 41375-90-0; benzene-1,2-dicarboxylic acid bis(6-methylheptyl) ester; C14577; DIISOOCTYL PHTHALATE (SEE 27554-26-3); Hexaplas M/O; 25103-50-8; Corflex 880; Flexol Plasticizer DIOP; 1,2-Benzenedicarboxylic acid, 2,2-dimethyl-1,3-propanediyl diisooctyl ester; Isooctyl phthalate | C24H38O4 | 390.6 g/mol | CC(C)CCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCC(C)C |
| TCMBANKIN059353 | citronellal | LMPR0102010007; 6-Octenal,3,7-dimethyl-,(3R)-; NEHNMFOYXAPHSD-SNVBAGLBSA-N; 6-Octenal,3,7-dimethyl-,(3R)-; d-citronellal; (R)-(+)-3,7-Dimethyl-6-octenal; FT-0604386; SCHEMBL457495; 3,7-Dimethyl-(3R)-6-Octenal; 6-octenal,3,7-dimethyl-,(3r)-; (R)-3,7-Dimethyloct-6-enal; 7-dimethyl-(theta)-6-octena; ()-Citronellal; EINECS 219-194-5; (R)-(+)-Citronellal; CHEBI:299; (R)-3,7-dimethyl-6-octenal; C09848; 2385-77-5; (+)-Citronellal; (3R)-3,7-dimethyloct-6-enal; AC1L2OQO; AC1Q6PO2; Citronella Java Oil; (3R)-3,7-Dimethyloct-6-enal (6-Octenal,3,7-dimethyl-,(3R)-); R-3,7-dimethyl-oct-6-enal; (3R)-(+)-citronellal; 6-Octenal,3,7-dimethyl-,(theta)-; EC 219-194-5; CCG-214393; (R)-(+)-Citronellal,technical grade,90%; 951036-03-6; AC1Q29GM; DTXSID6044482; 6-octenal,3,7-dimethyl-,(r)-; 6-Octenal,3,7-dimethyl-,(R)-; (r)-3,7-dimethyl-oct-6-enal; L-(-)-Citronellal; 3,7-Dimethyl-(3S)-6-Octenal; CHEMBL1081721; CTK8F2012; AC1Q29GL; CJ-24100; L-Citronellal; MFCD00067089; AKOS025311453; A801397; FT-0699573; ZINC1531600; (R)-citronellal; (3R)-3,7-Dimethyl-6-octenal; s-(-)-citronellal; UNII-QB99VZZ7GZ component NEHNMFOYXAPHSD-SNVBAGLBSA-N; 3,7-Dimethyl-6-octenal,(3R)-; 3,7-Dimethyl-(S)-6-Octenal; Citronellol 96%; (R)-(+)-Citronellal; CHEBI:299; 106-23-0; (R)-3,7-dimethyl-6-octenal; LMPR01020055; 2385-77-5; C09848; 343641_ALDRICH; 6-Octenal,3,7-dimethyl-,(3R)-; (3R)-3,7-dimethyloct-6-enal; ZINC01531600; (3R)-3,7-dimethyl-6-octenal; (3R)-(+)-citronellal; 6-Octenal,3,7-dimethyl-,(theta)-; (R)-3,7-Dimethyloct-6-enal; EINECS 219-194-5 | C10H18O | 154.25 | CC(CCC=C(C)C)CC=O |
| TCMBANKIN059524 | (1S,4R)-fenchone | C10H16O | 152.23 g/mol | CC1(C2CCC(C2)(C1=O)C)C | |
| TCMBANKIN059546 | Gypenoside LXIX | C53H90O22 | 1079.27 | CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)CO)O)O)OC5C(C(C(C(O5)CO)O)O)O)C)CC(C6C3(CCC6C(C)(CC=CC(C)(C)O)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C)O)C)C | |
| TCMBANKIN059547 | 16-oxodiepiserratenediol | C30H48O3 | 456.7 g/mol | CC1(C2CCC3(CC4=CC(=O)C5C(C(CCC5(C4CCC3C2(CCC1O)C)C)O)(C)C)C)C | |
| TCMBANKIN059551 | 2H-3,9a-Methano-1-benzoxepin-9-methanol, octahydro-2,2,5a-trimethyl-, (3R-(3alpha,5aalpha,9alpha,9aalpha))- | C15H26O2 | 238.37 | CC1(C2CCC3(CCCC(C3(C2)O1)CO)C)C | |
| TCMBANKIN059621 | ginsenoside-r0 | C48H76O19 | 957.1 g/mol | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)C(=O)O)O)O)OC7C(C(C(C(O7)CO)O)O)O)C)C)C2C1)C)C(=O)OC8C(C(C(C(O8)CO)O)O)O)C | |
| TCMBANKIN059624 | Araloside A | C47H74O18 | 927.08 | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)C(=O)O)OC7C(C(C(O7)CO)O)O)O)O)C)C)C2C1)C)C(=O)OC8C(C(C(C(O8)CO)O)O)O)C | |
| TCMBANKIN059635 | 18α-oleanane;oleanane | C30H52 | 412.73 | CC1(CCC2(CCC3(C(C2C1)CCC4C3(CCC5C4(CCCC5(C)C)C)C)C)C)C | |
| TCMBANKIN059651 | NSC 308879 | C30H52O3 | 460.73 | CC1(CCCC(O1)(C)C2CCC3(C2C(CC4C3(CCC5C4(CCC(C5(C)C)O)C)C)O)C)C | |
| TCMBANKIN059654 | 6892-80-4 | C15H26O | 222.37 g/mol | CC1(CCCC2(C1=CCC(CC2)(C)O)C)C | |
| TCMBANKIN059840 | 2,5-dimethylbenzaldehyde | C9H10O | 134.18 | CC1=CC(=C(C=C1)C)C=O | |
| TCMBANKIN059874 | pseudohypericin | C30H16O9 | 520.4 g/mol | CC1=CC(=O)C2=C(C3=C(C=C(C4=C3C5=C2C1=C6C(=CC(=O)C7=C(C8=C(C=C(C4=C8C5=C67)O)O)O)CO)O)O)O | |
| TCMBANKIN059947 | vitamin b1 | C63H88CoN14O14P | 1356.4 g/mol | CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+2] | |
| TCMBANKIN059948 | Vitamin- G | C17H20N4O6 | 376.36 | CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O | |
| TCMBANKIN059954 | Girinimbine | C18H17NO | 263.33 | CC1=CC2=C(C3=C1OC(C=C3)(C)C)NC4=CC=CC=C42 | |
| TCMBANKIN059962 | cadinen;α-Cadinene;1,2,4a,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)naphthalene;1,2,4A,5,6,8A-hexahydro--4,7-dimethyl-(1-methylethyl)-naphthalene;muurolene;1,2,4a,5,6,8a- hexhydro- 4,7- dimethyl- 1-(1- methylethyl)-(1alpha 4a． alpha．,8a alpha． )- naphthalene;alpha cadinene;α-muurolene | C15H24 | 204.35 g/mol | CC1=CC2C(CC1)C(=CCC2C(C)C)C | |
| TCMBANKIN059964 | α-cadinol | C15H26O | 222.37g/mol | CC1=CC2C(CCC(C2CC1)(C)O)C(C)C | |
| TCMBANKIN059975 | β-humulene | C15H24 | 204.35 | CC1=CCC(C=CCC(=C)CCC1)(C)C | |
| TCMBANKIN059976 | humulene | C15H24 | 204.35 g/mol | CC1=CCC(C=CCC(=CCC1)C)(C)C | |
| TCMBANKIN059977 | (1R,3E,7E,11R)-1,5,5,8-tetramethyl-12-oxabicyclo[9.1.0]dodeca-3,7-diene;Humulene-1,2-epoxide;humulene epoxide ii;Epoxy humulene;1,5,5,8--tetramethyl--12--oxygen-containing ring [9. 1.0], 12-3,7--Diene;［1R-(1R* ,3E,7E, 11R * )］- 1,5,5,8- tetramethyl- 12- oxabicyclo［9. 1. 0］dodeca- 3,7- diene;humulene epoxide i;humulene epoxide iii | C15H24O | 220.35 g/mol | CC1=CCC(C=CCC2(C(O2)CC1)C)(C)C | |
| TCMBANKIN059983 | β-bisabolene | C15H24 | 204.35 g/mol | CC1=CCC(CC1)C(=C)CCC=C(C)C | |
| TCMBANKIN060145 | rhamnose | C6H12O5 | 164.16 g/mol | CC1C(C(C(C(O1)O)O)O)O | |
| TCMBANKIN060182 | 20-(R)-Ginsenoside-Rg2 | C42H72O13 | 785.01 | CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CC4(C(CC(C5C4(CCC5C(C)(CCC=C(C)C)O)C)O)C6(C3C(C(CC6)O)(C)C)C)C)CO)O)O)O)O)O | |
| TCMBANKIN060183 | ginsenoside- Re | C48H82O18 | 947.15 | CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CC4(C(CC(C5C4(CCC5C(C)(CCC=C(C)C)OC6C(C(C(C(O6)CO)O)O)O)C)O)C7(C3C(C(CC7)O)(C)C)C)C)CO)O)O)O)O)O | |
| TCMBANKIN060184 | pseudoginsenoside f11 | C42H72O14 | 801 g/mol | CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CC4(C(CC(C5C4(CCC5C6(CCC(O6)C(C)(C)O)C)C)O)C7(C3C(C(CC7)O)(C)C)C)C)CO)O)O)O)O)O | |
| TCMBANKIN060237 | Smitilbin | C21H22O11 | 450.39 | CC1C(C(C(C(O1)OC2C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=CC(=C4)O)O)O)O)O | |
| TCMBANKIN060238 | isoengeletin | C21H22O10 | 434.39 g/mol | CC1C(C(C(C(O1)OC2C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)O)O)O | |
| TCMBANKIN060425 | Deoxygomisin A | C23H28O6 | 400.5 g/mol | CC1CC2=CC3=C(C(=C2C4=C(C(=C(C=C4CC1C)OC)OC)OC)OC)OCO3 | |
| TCMBANKIN060468 | (+)-calaren | C15H24 | 204.35 | CC1CCC=C2C1(C3C(C3(C)C)CC2)C | |
| TCMBANKIN060486 | isoerubioside b | C51H84O24 | 1081.2 g/mol | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC(C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)OC9C(C(C(C(O9)CO)O)O)O)OC2C(C(C(C(O2)CO)O)O)O)O)O)C)O)C)C)OC1 | |
| TCMBANKIN060512 | smilagenin | C27H44O3 | 416.6 g/mol | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)O)C)C)C)OC1 | |
| TCMBANKIN060561 | delta-guaiene | C15H24 | 204.35 g/mol | CC1CCC2=C(CCC(CC12)C(=C)C)C | |
| TCMBANKIN060566 | β-patchoulene | C15H24 | 204.35 | CC1CCC2=C1CC3CCC2(C3(C)C)C | |
| TCMBANKIN060575 | alpha-gurjunene | C15H24 | 204.35 g/mol | CC1CCC2C(C2(C)C)C3=C(CCC13)C | |
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060680 | stigmasterol-3-glucoside | C35H58O6 | 574.83 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN060691 | poriferast-5-en-3beta-ol;22,23-dihydrostigmasterol;gamma-sitosterol;clionasterol;beta-dihydrofucosterol | C29H50O | 414.71 g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060693 | Sitogluside | C35H60O6 | 576.85g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN060705 | methyl linoleate | C19H34O2 | 294.47 | CCC=CCC=CCC=CCCCCCCCC(=O)OC | |
| TCMBANKIN060807 | 3-methylheptane | C8H18 | 114.23 | CCCCC(C)CC | |
| TCMBANKIN060825 | 5-heptadec-12-enylresorcinol | C23H38O2 | 346.5 g/mol | CCCCC=CCCCCCCCCCCCC1=CC(=CC(=C1)O)O | |
| TCMBANKIN060834 | neocnidilide | C12H18O2 | 194.27 | CCCCC1C2CCCC=C2C(=O)O1 | |
| TCMBANKIN060852 | Undecane, 3,6-dimethyl | C13H28 | 184.36 | CCCCCC(C)CCC(C)CC | |
| TCMBANKIN060873 | arachidonic acid | C20H32O2 | 304.5 g/mol | CCCCCC=CCC=CCC=CCC=CCCCC(=O)O | |
| TCMBANKIN060905 | Ricineic acid | C18H32O2 | 280.45 | CCCCCCC=CC=CCCCCCCCC(=O)O | |
| TCMBANKIN060910 | cis-9-hexadecenoic acid | C16H30O2 | 254.41 g/mol | CCCCCCC=CCCCCCCCC(=O)O | |
| TCMBANKIN060922 | Octane | C8H18 | 114.23 g/mol | CCCCCCCC | |
| TCMBANKIN060935 | panaxynol | C17H24O | 244.37 | CCCCCCCC=CCC#CC#CC(C=C)O | |
| TCMBANKIN060939 | Ginsenoyne E | C17H22O2 | 258.35 g/mol | CCCCCCCC1C(O1)CC#CC#CC(=O)C=C | |
| TCMBANKIN060948 | 3- methyl-Undecane | C14H30 | 198.39 g/mol | CCCCCCCCC(C)CC(C)C | |
| TCMBANKIN060973 | malic acid | C18H32O2 | 280.4 g/mol | CCCCCCCCC1=C(C1)CCCCCCC(=O)O | |
| TCMBANKIN061016 | tridecane | C13H28 | 184.36 g/mol | CCCCCCCCCCCCC | |
| TCMBANKIN061024 | tetradecane | C14H28 | 196.39 g/mol | CCCCCCCCCCCCC=C | |
| TCMBANKIN061030 | Methyl myristate | C15H30O2 | 242.4 g/mol | CCCCCCCCCCCCCC(=O)OC | |
| TCMBANKIN061036 | methyl pentadecanoate | C16H32O2 | 256.42 | CCCCCCCCCCCCCC(C)C(=O)O | |
| TCMBANKIN061043 | MYS | C15H32 | 212.41 | CCCCCCCCCCCCCCC | |
| TCMBANKIN061044 | Pentadecanoate | C15H29O2- | 241.39 g/mol | CCCCCCCCCCCCCCC(=O)[O-] | |
| TCMBANKIN061045 | PENTADECYLIC ACID | C15H30O2 | 242.4 g/mol | CCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061058 | n-hexadecane | C16H34 | 226.44 g/mol | CCCCCCCCCCCCCCCC | |
| TCMBANKIN061071 | Ethylpalmitate | C18H36O2 | 284.5 g/mol | CCCCCCCCCCCCCCCC(=O)OCC | |
| TCMBANKIN061085 | n-heptadecane;heptadecane;Heptadekan | C17H36 | 240.5 g/mol | CCCCCCCCCCCCCCCCC | |
| TCMBANKIN061086 | Methyl margarate | C18H36O2 | 284.48; 284.5 g/mol | CCCCCCCCCCCCCCCCC(=O)OC | |
| TCMBANKIN061093 | ethyloctadecanoate | C20H40O2 | 312.5 g/mol | CCCCCCCCCCCCCCCCCC(=O)OCC | |
| TCMBANKIN061100 | nonadecane | C19H40 | 268.5 g/mol | CCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061102 | LFA | C20H42 | 282.55 g/mol | CCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061120 | Nonacosanediol-6,8 | C29H60O2 | 440.79 | CCCCCCCCCCCCCCCCCCCCCC(CC(CCCCC)O)O | |
| TCMBANKIN061124 | Methyl tricosanoate;tricosanoicacid,methylester | C24H48O2 | 368.64 | CCCCCCCCCCCCCCCCCCCCCCC(=O)OC | |
| TCMBANKIN061139 | n-nonacosane | C29H60 | 408.79 g/mol | CCCCCCCCCCCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061165 | Acetic acid, octadecyl ester | C20H40O2 | 312.53 g/mol | CCCCCCCCCCCCCCCCCCOC(=O)C | |
| TCMBANKIN061170 | heptadecanol | C17H36O | 256.47 | CCCCCCCCCCCCCCCCCO | |
| TCMBANKIN061174 | Tetradecanol | C14H30O | 214.39 g/mol | CCCCCCCCCCCCCCO | |
| TCMBANKIN061177 | dodecanol | C12H26O | 186.33 g/mol | CCCCCCCCCCCCO | |
| TCMBANKIN061203 | dibutyl oxalate | C10H18O4 | 202.25 g/mol | CCCCOC(=O)C(=O)OCCCC | |
| TCMBANKIN061207 | Di-n-butyl phthalate | C16H22O4 | 278.34 g/mol | CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC | |
| TCMBANKIN061264 | 1,1-diethoxy ethane;Acetal | C6H14O2 | 118.17 g/mol | CCOC(C)OCC | |
| TCMBANKIN061354 | Fumarine | C05189; TNP00339; 7-methyl-2,3:9,10-bis[methylenebis(oxy)]-7,13a-secoberbin-13a-one; ST036759; Bis[1,3]benzodioxolo[4,5-c:5',6'-g]azecin-13(5H)-one, 4,6,7,14-tetrahydro-5-methyl-; Bis(1,3)benzodioxolo(4,5-c:5',6'-g)azecin-13(5H)-one, 4,6,7,14-tetrahydro-5-methyl-; HSCI1_000268; EINECS 204-999-6; AIDS-040935; Corydinine; 4,6,7,14-Tetrahydro-5-methyl-bis(1,3)benzodioxolo(4,5-c-5',6'-g)azecin-13(5H)-one; Oprea1_722246; NCGC00142402-01; Biflorine; Macleyine; 130-86-9; NCGC00017389-01; 7-methyl-6,8,9,16-tetrahydrobis[1,3]benzodioxolo[4,5-c:5',6'-g]azecin-15(7H)-one; 7,13a-Secoberbin-13a-one, 7-methyl-2,3:9,10-bis(methylenedioxy)-; Alk-3; 6164-47-2 (HCL); Oprea1_718853; AIDS040935; 7-Methyl-2,3:9,10-bis(methylenedioxy)-7,13a-secoberbin-13a-one; HSDB 3527; CHEBI:16415; AI3-62909; ACon1_001550; DTXSID00178935; Bis(1,3)benzodioxolo(5,6-c:5',6'-g)azecin-14(6H)-one, 5,7,8,15-tetrahydro-6-methyl-; Bis[1,3]benzodioxolo[5,6-c:5',6'-g]azecin-14(6H)-one,5,7,8,15-tetrahydro-6-methyl-; AC1L4H3I; CHEMBL486179; 14-METHYL-7,9,20,22-TETRAOXA-14-AZAPENTACYCLO[15.7.0.0?,(1)(2).0?,(1)?.0(1)?,(2)(3)]TETRACOSA-1(24),4,6(10),11,17,19(23)-HEXAEN-2-ONE; CTK4F3162; MCULE-2865552640; BDBM50377937; 24240-05-9; AC1Q6P91; NCGC00385257-01_C20H19NO5_1,3-Benzodioxolo[5,6-c][1,3]benzodioxolo[5,6-g]azecin-14(6H)-one, 5,7,8,15-tetrahydro-6-methyl-; C20H19NO5; protopine ; Pseudoprotopine; MolPort-028-610-216; 6-methyl-5,7,8,15-tetrahydrobis[1,3]benzodioxolo[5,6-c:5',6'-g]azecin-14(6h)-one; 7,13a-Secoberbin-13a-one, 7-methyl-2,3:10,11-bis(methylenedioxy)-; ZINC31502517; protopine | C20H19NO5 | 353.37 | CN1CCC2=CC3=C(C=C2C(=O)CC4=C(C1)C5=C(C=C4)OCO5)OCO3 |
| TCMBANKIN061664 | eupafolin | 6-methoxy-5,7,3',4'-tetrahydroxyflavone; eupafolin;Nepetin;6-methoxyluteolin;NSC122416; Flavone, 3',4',5,7-tetrahydroxy-6-methoxy-; nepetin; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-methoxy-; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-methoxychromen-4-one; AIDS027676; MLS000728561; NSC 122416; ST5309235; SMR000440634; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-methoxy- (9CI); AIDS-027676; Flavone, 3',4',5,7-tetrahydroxy-6-methoxy- (8CI); 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-methoxy-chromone; 5,7,3',4'-Tetrahydroxy-6-methoxyflavone; EUPAFOLIN; MLS000877025; MEGxp0_000458; 6-Methoxyluteolin; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-methoxy-4-chromenone; ACon1_000516; 520-11-6; ZINC01081536; NCGC00163594-01; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-methoxy-chromen-4-one | C16H12O7 | 316.26 g/mol | COC1=C(C2=C(C=C1O)OC(=CC2=O)C3=CC(=C(C=C3)O)O)O |
| TCMBANKIN061745 | syringic acid; Syryngic; 1,5-dimethoxy-3-hydroxybenzoicacid; 3,5-dimethoxy-4-hydroxybenzoic acid; Cedar acid | I01-1212; syringicacid; 3,5-dimethoxy-4-oxidanyl-benzoate; CHEBI:132111; 4-hydroxy-3,5-dimethoxybenzoate; c1409; ZB006317; AKOS015888648; A824548; A829374; CJ-01507; AC1OC351; ST51051575; C10833; DivK1c_006581; KBio3_002814; 530-57-4; AI3-24376; 3,5-Dimethoxy-4-hydroxybenzyl acid; S6881_SIGMA; BSPBio_003312; InChI=1/C9H10O5/c1-13-6-3-5(9(11)12)4-7(14-2)8(6)10/h3-4,10H,1-2H3,(H,11,12; EINECS 208-486-8; Gallic acid 3,5-dimethyl ether; Syringic acid; NSC2129; Spectrum3_001866; 4-10-00-01995 (Beilstein Handbook Reference); 4-Hydroxy-3,5-dimethoxybenzoic acid; SpecPlus_000485; NSC 2129; 4-hydroxy-3,5-dimethoxy-benzoic acid; Spectrum5_000963; ST5214746; KBio1_001525; BRN 2115262; 3,5-Dimethoxy-4-hydroxybenzoic acid; Benzoic acid, 4-hydroxy-3,5-dimethoxy- | C9H10O5 | 198.17 g/mol | COC1=CC(=CC(=C1O)OC)C(=O)O |
| TCMBANKIN061786 | elemicine | el-emicine，Elemicine; elemicin ; Elemicin; Benzene, 5-(2-propenyl)-1,2,3-trimethoxy; AX8052814; CJ-04512; C10451; V6154; KS-00000EX2; TC-307841; 4-allyl-1,2,6-trimethoxybenzene; CHEBI:4771; KB-85683; 5-Allyl-1,2,3-trimethoxybenzene; 1,2,3-Trimethoxy-5-allylbenzene; NSC16704; K-9190; BRN 1912664; TRA0018883; 5-(Prop-2-en-1-yl)-1,2,3-trimethoxybenzene; 1,2,3-Trimethoxy-5-allylbenzene (elemicin); SCHEMBL68542; EINECS 207-649-0; CTK4J0963; 5'-metoxy eugenol; ZB015169; ST24044297; AKOS015896443; CCRIS 6783; Benzene, 1,2,3-trimethoxy-5-(2-propenyl)-; 10005-761a; 1,2,3-Trimethoxy-5-(2-propenyl)-benzene; 1,2,3-trimethoxy-5-(prop-2-en-1-yl)benzene; Benzene,1,2,3-trimethoxy-5-(2-propen-1-yl)-; A827594; 1,2,3-Trimethoxy-5-[2-propenyl]-benzene; I06-1928; 1,2,3-Trimethoxy-5-(2-propenyl)benzene; DTXSID60197586; ZINC899845; 3,4,5-Trimethoxyallylbenzene; MFCD01656688; BPLQKQKXWHCZSS-UHFFFAOYSA-N; AI3-20815; AN-843; CHEMBL458690; 487A116; OR40002; 487-11-6; 5-allyl-1,2,3-trimethoxybenzene; AK116942; ZX-AT003475; Benzene, 1,2,3-trimethoxy-5-(2-propenyl)- (9CI); J-520432; NSC-16704; MolPort-003-824-417; 3,4, 5-Trimethoxyallylbenzene; RP26424; LS-29056; 5-allyl-1,2,3-trimethoxy-benzene; HSZ191AKAN; AC1L1USQ; 4-allyl-1,2,6-trimethoxy benzene; 1,2,3-Trimethoxy-5-(2-propenyl)benzene, 9CI; NSC 16704; AJ-24292; Benzene,2,3-trimethoxy-5-(2-propenyl)-; SY018605; 1,2,3-trimethoxy-5-prop-2-enyl-benzene; 1,2,3-trimethoxy-5-prop-2-enylbenzene; FT-0652063; ST51053296; Benzene, 5-allyl-1,2,3-trimethoxy-; BENZENE, 5-ALLYL-1,2,3-TRIMETHOXY-; DB-081347; 3,5-Trimethoxyallylbenzene; PS-4970; UNII-HSZ191AKAN; 3-(3,4,5-Trimethoxyphenyl)-1-propene; 4-06-00-07478 (Beilstein Handbook Reference) | C12H16O3 | 208.25 g/mol | COC1=CC(=CC(=C1OC)OC)CC=C |
| TCMBANKIN061822 | 4-methoxybenzaldehyde | KS-000002NI; EC 204-602-6; anisaldehyd; 4-methoxylbenzaldehyde; SBB040224; FEMA No. 2670; DB-012818; 4-Methoxybenzaldehyde; 4-(methyloxy)benzaldehyde; A0480; MFCD00003385; CJ-01596; SC-26765; 4-Methoxybenzaldehyde, 98% 50g; bmse010130; AK-72956; BENZALDEHYDE,4-METHOXY MFC8 H8 O2; 4-methoxybenzoyl; 4-Anisaldehyde; NCGC00257076-01; AN-22903; EBD1062; I922; P-ANISALDEHYDE; p-Anisic aldehyde; p-Methoxybenzaldehyde; Anisaldehyde; anisal; 79582-EP2305698A2; 4-methoxybenzaldehye; BG01497623; C10761; EINECS 256-891-3; DSSTox_RID_78277; Methoxybenzaldehyde (Related); EINECS 204-602-6; KB-193002; BB_NC-2206; AS02988; NSC 5590; p-Anisaldehyde, natural, 98%, FG; Benzaldehyde, 4-methoxy-; 4-Methoxy-benzaldehyde; HMS3039F08; p-Methoxybenzylidenemalonitrile; DSSTox_GSID_26997; 4-methoxybenzene carboxaldehyde; I01-0482; 123-11-5; anisic aldehyde (natural); UNII-9PA5V6656V; RP20260; AJ-14902; p-Anisaldehyde, United States Pharmacopeia (USP) Reference Standard; Q-100105; 79582-EP2292628A2; ST50213373; Anisaldehyde solution; 79582-EP2374783A1; DTXSID2026997; p-Methoxy Benzaldehyde, Natural; NCGC00090807-01; KB-115367; ZINC157146; p-Anisaldehyde, primary pharmaceutical reference standard; AI3-00223; 68894-36-0; 79582-EP2298755A1; AC-10379; AC1L1L81; CHEMBL161598; p-Anisaldehyde, for synthesis, 98.0%; 4-methoxy-benzaldehyde; LS-20018; 29578-EP2308838A1; CAS-123-11-5; SCHEMBL1100; 29578-EP2311825A1; InChI=1/C8H8O2/c1-10-8-4-2-7(6-9)3-5-8/h2-6H,1H; SMR001224521; p-Anisaldehyde, 8CI; 29578-EP2305696A2; 4-08-00-00252 (Beilstein Handbook Reference); LS-2093; 79582-EP2305695A2; para-methoxybenzaldehyde; 26249-15-0; ZRSNZINYAWTAHE-UHFFFAOYSA-N; CHEBI:28235; NATURAL ANISIC ALDEHYDE; DSSTox_CID_6997; p-Formylanisole; Anisaldehyde; p-Anisaldehyde (4-Methoxybenzaldehyde); ACMC-1BAZN; 29578-EP2305695A2; Formylanisole, p-; WLN: VHR DO1; p-Anisaldehyde, 98%; p-Methoxybenzafdehyde; BRN 0471382; ZB006571; Caswell No. 051E; ST2411506; FT-0617622; 4-Methoxybenzaldhyde; p-Anisaldehyde, certified reference material, TraceCERT(R); KSC174M6D; 29578-EP2311842A2; NCGC00259492-01; p-Methoxybenzaldehyde (natural); p-Anisaldehyde, >=97.5%, FCC, FG; p-Methoxybenzaldehyde; Tox21_303331; 721942-53-6; p-Anisic aldehyde; 3-Chlorobenzenesulfonyl chloride, 98%; 79582-EP2305696A2; MLS002152921; RTR-003659; A805017; p-Anisaldehyde, analytical standard; 4-methoxy benzaldehyde; Anis aldehyde; para-anisaldehyde; 4-methoxybezaldehyde; HSDB 2641; 29578-EP2284160A1; PubChem22535; Aubepine; 29578-EP2305698A2; Jsp001555; I01-8766; ANW-18100; 79582-EP2305697A2; AKOS000118814; 29578-EP2292628A2; M-6033; Anisic aldehyde; CTK0H4661; BR-72956; TR-003659; TRA0080347; 79582-EP2287153A1; BBL027436; Tox21_201943; NCGC00090807-02; NSC-5590; para-methoxy benzaldehyde; Obepin; CCG-214805; MolPort-000-871-198; CS-W020189; FEMA 2670; Anisaldehyde (para); 79582-EP2377841A1; 29578-EP2305697A2; MCULE-9537754812; F2190-0575; 9PA5V6656V; p-methoxy benzaldehyde; AC1Q4CCF; NSC5590; CCRIS 821; BDBM50139370; Crategine;anisaldehyde;p-Anis aldehyde;AI3-00223; 4-Anisaldehyde; Crategine; 26249-15-0; p-Methoxybenzaldehyde (natural); EINECS 204-602-6; C10761; 19486-71-6; 68894-36-0; NSC 5590; 4-Methoxybenzaldehyde-; CCRIS 821; Aubepine; ZINC00157146; InChI=1/C8H8O2/c1-10-8-4-2-7(6-9)3-5-8/h2-6H,1H; WLN: VHR DO1; Anisaldehyde solution; (4-METHOXYPHENYL)((2)H)FORMALDEHYDE; Benzaldehyde, 4-methoxy-; Benzaldehyde, methoxy-; ST5213373; p-Formylanisole; W267007_ALDRICH; HSDB 2641; A-d1; 4-08-00-00252 (Beilstein Handbook Reference); deuterio-(4-methoxyphenyl)methanone; Obepin; p-Anisaldehyde; Aub+ pine; NSC5590; ANISALDEHYDE; 4-Methoxybenzaldehyde; 97063_FLUKA; 123-11-5; FEMA No. 2670; p-Anisic aldehyde; Caswell No. 051E; BRN 0471382; 50984-52-6; DTXSID40460063; A88107_ALDRICH; 4-Methoxybenzaldehyde-alpha-d1, 98 atom % D; 4-Methoxybenzaldehyde-alpha-d1; p-Methoxybenzaldehyde; Formylanisole, p-; BENZALDEHYDE,4-METHOXY MFC8 H8 O2; LS-2093; Anisic aldehyde; EINECS 256-891-3; NCGC00090807-01; Methoxybenzaldehyde; SRA1_SIAL; p-Anisaldehyde-;p-anisaldehyde | C8H8O2 | 136.15 g/mol | COC1=CC=C(C=C1)C=O |
| TCMBANKIN061849 | 1-methoxy-4-(2-propenyl)-benzene | 4-Allylanisole;estragole;esdragol;Terragon;methylchavicol;CCRIS 1317; MolPort-000-156-967; MFCD00008653; Estragol (methylchavicol); DSSTox_CID_575; Anisole, p-allyl-; Esdragol; 1-allyl-4-methoxy-benzene; DTXSID0020575; 4-allylanisol; Methyl chavicole (estragole); p-Methoxyallylbenzene; Benzene, 1-methoxy-4-(2-propen-1-yl)-; NCGC00091434-01; chavicyl methylether; CTK7A3557; Methyl chavicole; UNII-9NIW07V3ET; Estragol; SR-01000838348; 4-06-00-03817 (Beilstein Handbook Reference); Ether, p-allylphenyl methyl; NSC 404113; Tarragon; 140-67-0; DSSTox_RID_75667; O080; Chavicol methyl ether; Benzene, 1-methoxy, 4-prop-2-enyl; AK109291; FEMA No. 2411; p-Allylphenyl methyl ether; p-allylanisole, 4-allyl-1-methoxybenzene, methyl chavicol; Chavicol, O-methyl-; NSC-404113; CHEMBL470671; CCG-214642; 4-Allylanisole, analytical standard; FEMA 2411; 1-METHOXY-4-(2-PROPENYL)BENZENE; FEMA Number 2411; EPA Pesticide Chemical Code 062150; 4-Allylmethoxybenzene; Benzene, 1-methoxy-4-(2-propenyl)-; HMS2268E24; SMR000112379; p-Allylanisole; SPECTRUM1505117; 1-methoxy-4-(prop-2-en-1-yl)benzene; Chavicyl methyl ether; chavicol methylether; C10452; NCI-C60946; Allylphenyl methyl ether, p-; estragon;p-allylanisole; EINECS 205-427-8; AI3-16052; Esteragol; ZINC967635; 4-Allylanisole, purum, >=97.0% (GC); CHEBI:4867; 1407-27-8; Estragole (natural); NCGC00259936-01; MLS001065575; 1-methoxy-4-prop-2-enylbenzene; Methyl chavicol; AC1Q4FE9; 1-Methoxy-4-(2-propen-1-yl)-Benzene; Methylchavicol; Chavicol, methyl-; p-Allyl-Anisole; ACMC-1BW75; KB-36193; 3-(p-Methoxyphenyl)propene; 1-methoxy-4-(2-propenyl)-benzene; InChI=1/C10H12O/c1-3-4-9-5-7-10(11-2)8-6-9/h3,5-8H,1,4H2,2H; AKOS000121300; p-Allylmethoxybenzene; Methyl-Chavicol; AC1L1RR7; Tox21_302930; 3-(4-Methoxyphenyl)-1-propene; ST50824126; BRN 1099454; Isoanthethole; LS-821; Esdragon; ZFMSMUAANRJZFM-UHFFFAOYSA-N; I01-10181; Estragole, analytical standard; 9NIW07V3ET; O-Methyl-Chavicol; Terragon; 4-Allyl-1-methoxybenzene; BENZENE,1-ALLYL,4-METHOXY METHYLCHAVICOL; HSDB 5412; 4-Allylanisole, 98%; Chavicyl methyl ether; AN-17349; 1-Methoxy-4-(2-propenyl)benzene, 9CI; A0702; 4-Allylanisole; para-allylanisole; AC1Q4CFH; SCHEMBL57204; WLN: 1U2R DO1; SR-01000838348-2; FT-0617414; J-007415; NCGC00091434-02; TC-109325; CAS-140-67-0; isoanethole, 4-Allylanisole; ANW-20580; 4-Methoxyallylbenzene; Tox21_202387; Estragole; NSC404113; Esdragole; 77525-18-9; AJ-24538; DSSTox_GSID_20575; NCGC00091434-03; Para-allylanisole (estragole); ZB015470; BENZENE,1-ALLYL,4-METHOXY METHYLCHAVICOL; 1-Allyl-4-methoxybenzene; NCGC00256481-01; 4-Allylanisole, >=98%, FCC; 1-Methoxy-4-(2-propen-1-yl)benzene; Isoanethole;34098_RIEDEL; 3-(p-Methoxyphenyl)propene; InChI=1/C10H12O/c1-3-4-9-5-7-10(11-2)8-6-9/h3,5-8H,1,4H2,2H; 1-METHOXY-4-(2-PROPENYL)BENZENE; Anisole, p-allyl-; EPA Pesticide Chemical Code 062150; 1-allyl-4-methoxy-benzene; Esdragol; FEMA Number 2411; p-Allylmethoxybenzene; NCGC00091434-02; 4-Allylmethoxybenzene; Benzene, 1-methoxy-4-(2-propenyl)-; p-Methoxyallylbenzene; 4-Methoxyallylbenzene; BRN 1099454; WLN: 1U2R DO1; SPECTRUM1505117; p-Allylanisole; LS-821; Esdragon; NCGC00091434-01; Estragol; Chavicyl methyl ether; C10452; Estragole; 4-06-00-03817 (Beilstein Handbook Reference); NSC404113; Esdragole; NCI-C60946; NSC 404113; 77525-18-9; 4-Allyl-1-methoxybenzene; Tarragon; 140-67-0; Allylphenyl methyl ether, p-; HSDB 5412; EINECS 205-427-8; ZINC00967635; AI3-16052; Isoanethole; 1-methoxy-4-prop-2-enyl-benzene; A29208_ALDRICH; 05820_FLUKA; Chavicol methyl ether; 05818_FLUKA; BENZENE,1-ALLYL,4-METHOXY METHYLCHAVICOL; 1407-27-8; W241105_ALDRICH; Estragole (natural); 1-Allyl-4-methoxybenzene; FEMA No. 2411; 4-Allylanisole; 1-Methoxy-4-(2-propen-1-yl)benzene; Chavicol, O-methyl-; 1-methoxy-4-prop-2-enylbenzene; Methyl chavicol; Methylchavicol | C10H12O | 148.2 g/mol | COC1=CC=C(C=C1)CC=C |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab